Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E16.54 EPS (ttm)11.00 Insider Own0.20% Shs Outstand728.68M Perf Week-1.92%
Market Cap132.55B Forward P/E14.20 EPS next Y12.81 Insider Trans-0.56% Shs Float728.62M Perf Month-2.97%
Income8.17B PEG3.78 EPS next Q3.10 Inst Own80.60% Short Float1.13% Perf Quarter2.49%
Sales23.05B P/S5.75 EPS this Y13.10% Inst Trans-0.01% Short Ratio3.32 Perf Half Y12.81%
Book/sh43.22 P/B4.21 EPS next Y1.86% ROA10.40% Target Price189.70 Perf Year12.35%
Cash/sh53.83 P/C3.38 EPS next 5Y4.38% ROE26.60% 52W Range133.64 - 191.10 Perf YTD24.41%
Dividend4.60 P/FCF18.19 EPS past 5Y20.50% ROI13.00% 52W High-2.70% Beta1.40
Dividend %2.53% Quick Ratio5.80 Sales past 5Y8.10% Gross Margin82.20% 52W Low39.13% ATR2.99
Employees19200 Current Ratio6.20 Sales Q/Q2.10% Oper. Margin44.70% RSI (14)58.05 Volatility1.28% 1.48%
OptionableYes Debt/Eq1.11 EPS Q/Q17.80% Profit Margin35.50% Rel Volume1.03 Prev Close181.90
ShortableYes LT Debt/Eq1.06 EarningsOct 25 AMC Payout38.80% Avg Volume2.48M Price185.94
Recom2.40 SMA200.12% SMA503.40% SMA2009.71% Volume2,035,615 Change2.22%
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Feb-08-16Reiterated Argus Buy $202 → $185
Jan-20-16Initiated Credit Suisse Outperform $205
Dec-15-15Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-04-15Initiated Wells Fargo Market Perform
Oct-29-15Reiterated UBS Buy $168 → $180
Sep-01-15Initiated Raymond James Mkt Perform
Jul-31-15Reiterated RBC Capital Mkts Outperform $185 → $190
Oct-17-17 09:44AM  Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen Zacks
Oct-16-17 04:00PM  Amgen And Boston Children's Hospital Enter A Collaboration To Find New Genes And Drug Targets For Severe Pain Syndromes PR Newswire
03:59PM  Pharma Industry Outlook - October 2017 Zacks
Oct-13-17 11:18AM  Can Biotech Stay Healthy Through the End of 2017? Barrons.com
Oct-12-17 09:00AM  Amgen Foundation Awards Khan Academy $3 Million To Support Development Of Free Comprehensive Biology Lessons PR Newswire
Oct-11-17 05:58PM  Dow's Merck Bails On Cholesterol Drug, Prodding Shares Down Investor's Business Daily
01:14PM  Mylan Receives CRL for Neulasta Biosimilar GuruFocus.com
08:07AM  Biotech Stock Roundup: Amgen's Imlygic Data Promising, Regeneron Scores Win in PCSK9 Lawsuit Zacks
Oct-10-17 07:00PM  Amgen Wins Reprieve on Its 2nd-Best-Selling Drug Motley Fool
11:05AM  Amgen Puerto Rico Staff Keeping Plant Open Despite Personal Losses From Hurricane Maria Forbes
11:00AM  Amgen Label Expansion Application for Prolia Accepted by FDA Zacks
10:38AM  Tezepelumab Could Help Amgen Develop Its Inflammation Franchise Market Realist
09:10AM  Amgens Pipeline Could Boost Its Long-Term Growth Opportunities Market Realist
07:41AM  If Approved, Aimovig Could Strengthen Amgens Neurology Portfolio Market Realist
Oct-09-17 04:00PM  FDA Accepts Supplemental Biologics License Application For Prolia® (Denosumab) In Glucocorticoid-Induced Osteoporosis PR Newswire
02:28PM  [$$] Ruling Goes Regeneron's Way Barrons.com
10:39AM  Biosimilars Could Boost Amgens Revenue Growth Market Realist
10:20AM  Forget Teva (TEVA), Buy These 5 Drug Stocks Instead Zacks
10:13AM  Cancer Space Last Week Update: Pipeline Expansion in Focus Zacks
09:13AM  Repatha Could Be Amgens Long-Term Growth Driver Market Realist
08:01AM  See what the IHS Markit Score report has to say about Amgen Inc. Markit
07:44AM  Analysts Recommendations for Amgen in October 2017 Market Realist
Oct-08-17 08:01AM  AbbVie's Fast Becoming a Top Stock to Buy Now Motley Fool
Oct-07-17 10:43AM  3 Blockbuster Drugs That Still Cost More Than They Should Motley Fool
Oct-06-17 07:00PM  3 Top Stocks Wall Street Insiders Love Motley Fool
06:27PM  FDA: Drug shortages possible due to Puerto Rico power outage Associated Press
05:37PM  Why Regeneron's Patent Win Is Worse For Amgen Than You Think Investor's Business Daily
04:01PM  Amgen And LabCentral Open Nomination Process For Lab Residency PR Newswire
09:00AM  Regeneron and Sanofi Get Favorable Ruling Against Amgen Zacks
08:20AM  Today's Research Reports on Stocks to Watch: Amgen and Regeneron ACCESSWIRE
07:18AM  Everything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now? Motley Fool
Oct-05-17 04:50PM  Regeneron Pops After Judge Tosses Ban On Amgen-Rivaling Med Investor's Business Daily
04:30PM  First Randomized Study To Evaluate IMLYGIC® (Talimogene Laherparepvec), An Oncolytic Viral Therapy, In Combination With A Checkpoint Inhibitor Published In The Journal Of Clinical Oncology PR Newswire
01:51PM  [$$] Appeals Court Rules Against Amgen in Patent Case The Wall Street Journal
01:14PM  U.S. court reverses ban on sale of Regeneron, Sanofi cholesterol drug Reuters
01:01PM  Regeneron spiking on court ruling vs. Amgen CNBC Videos
11:13AM  Why Amgen is Sliding Barrons.com
10:32AM  AbbVie (ABBV) Stock Up Almost 17% in One Month: Here's Why Zacks
03:00AM  Stocks With Rising Relative Strength: Amgen Investor's Business Daily
Oct-04-17 04:25PM  CytomX Breaks Out On Mash-Up With Amgen In Immuno-Oncology Investor's Business Daily
03:49PM  Amgen, CytomX Join in Immuno-Oncology Collaboration GuruFocus.com
02:00PM  Why Biotech's Rally May Push These 8 Stocks Even Higher Investopedia
09:11AM  Amgen Enters Into an Immuno-Oncology Partnership With CytomX Zacks
07:54AM  Biotech Stock Roundup: Endocyte Shoots up on Deal, Amgen-AbbVie Settle Humira Litigation Zacks
Oct-03-17 09:00PM  Why Shares in AbbVie Soared 18% in September Motley Fool
05:07PM  CytomX stock rockets 35% after deal with Amgen MarketWatch
04:15PM  Earnings Win Lifts This Sector; 2 Top Equity Plays In Buy Zone Investor's Business Daily
04:05PM  Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology PR Newswire
09:30AM  3 Top-Ranked Big Biotech Stocks to Buy Now Zacks
Oct-02-17 11:00PM  [$$] Stock market winners of 2008's crash had one thing in common Financial Times
04:02PM  AbbVie Patent Deal Staves Off Amgen Competition, But Others Lurk Investor's Business Daily
12:18PM  Plenty Of Opportunity In AbbVie, Even After Recent Run Benzinga
11:38AM  AbbVie Stock Upgraded: What You Need to Know Motley Fool
10:03AM  AbbVie: Better Late Than Never Barrons.com
Sep-29-17 03:09PM  AbbVie, Amgen Resolve Humira Patent Dispute GuruFocus.com
11:55AM  AbbVie's Humira Is an Ageless Wonder Bloomberg
10:44AM  AbbVie and Applied Materials Rose on September 28 Market Realist
09:28AM  How Will Trump's Proposed Tax Reform Impact Drug Companies? Zacks
09:25AM  Ligand's Captisol Deals Set to Drive Growth in the Long Run Zacks
07:24AM  Amgens rival to AbbVies Humira to launch in 2023 MarketWatch
06:04AM  How Good Is AbbVie's Humira Deal With Amgen? Motley Fool
12:07AM  AbbVie, Amgen Reach Settlement in Humira Patent Dispute The Wall Street Journal
Sep-28-17 05:44PM  AbbVie, Amgen Reach Humira Settlement The Wall Street Journal
04:52PM  Why Amgen's Drug Win Sent AbbVie Stock Into The Stratosphere Investor's Business Daily
04:30PM  Why BlackBerry, AbbVie, and bluebird bio Jumped Today Motley Fool
12:46PM  AbbVie: Has the Humira Cloud Lifted? Barrons.com
09:50AM  UPDATED: Under Amgen and AbbVie agreement, rival drug to AbbVie's Humira expected to launch in 2023 MarketWatch
08:00AM  Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA PR Newswire
Sep-27-17 03:00PM  5 Stocks That May Win Big FromTax Reform Investopedia
10:25AM  Short Sellers Hike Bets in Major Biotechs 24/7 Wall St.
08:01AM  Hurricane Maria devastation in Puerto Rico could cause drug shortages elsewhere MarketWatch
08:01AM  See what the IHS Markit Score report has to say about Amgen Inc. Markit
07:31AM  Trade of the Day: Amgen, Inc. (AMGN) Stock Has Plenty More Upside InvestorPlace
Sep-26-17 04:00PM  Amgen And Simcere Announce Strategic Collaboration To Co-Develop And Commercialize Biosimilars In China PR Newswire
11:44AM  These Companies Gain If Trump's Foreign Profit Relief Plan Passes Investor's Business Daily
08:25AM  Biotech Stock Roundup: Amgen Reiterates 2017 Outlook, Intercept Hit by Ocaliva Safety Issues Zacks
08:00AM  See what the IHS Markit Score report has to say about Amgen Inc. Markit
06:00AM  Why Risky Biotechs Are Rising as Tech Stocks Slump Investopedia
Sep-25-17 09:47AM  Amgen reaffirms 2017 guidance in wake of Hurricane Maria MarketWatch
09:00AM  Amgen Provides Update On Hurricane Maria PR Newswire
Sep-22-17 04:53PM  Amgen Foundation Pledges Up To $5 Million To Hurricane Maria Relief Efforts PR Newswire
06:00AM  Gilead, Amgen, and Biogen May Lift Biotech Higher Investopedia
Sep-21-17 10:25AM  Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake Zacks
08:00AM  See what the IHS Markit Score report has to say about Amgen Inc. Markit
Sep-20-17 08:01PM  AMGEN (AMGN) ALERT: Johnson Fistel Announces Investigation of Amgen Inc.; Investors that Bought Before March 17, 2017, Encouraged to Contact the Firm PR Newswire
01:00PM  deCODE Study Reveals an Ancient Achilles Heel in the Human Genome PR Newswire
08:00AM  See what the IHS Markit Score report has to say about Amgen Inc. Markit
Sep-19-17 08:31PM  Amgen challenge to Genentech $6 billion cancer drug OK'd by FDA American City Business Journals
09:40AM  Is Amgen (AMGN) a Great Stock for Value Investors? Zacks
08:02AM  How This Immigrant Entrepreneur Built A $5 Billion Healthcare Company Forbes
Sep-18-17 01:06PM  We're not chasing electric utilities: Heartland Financial... CNBC Videos
11:35AM  Gilead Sciences: Is The Kite Deal Too Little, Too Late? Barrons.com
05:00AM  FDA Clears Biotech Drug Copycats, But Buying Them Isnt So Easy Bloomberg
Sep-17-17 12:17PM  3 Great Income Stocks That Could Double Their Dividends Motley Fool
Sep-15-17 10:05PM  FDA Approves First 'Biosimilar' for Cancer Treatment TheStreet.com
05:46PM  Top Research Reports for Philip Morris, Amgen & Union Pacific Zacks
01:18PM  Why Amgen, Lilly, J&J Are Interested In These Small Biotechs Investor's Business Daily
10:33AM  Amgen/Allergan's Avastin Biosimilar Secures FDA Approval Zacks
04:32AM  New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes PR Newswire
Sep-14-17 09:30PM  A Biosimilar Cure for Sky-High Cancer Drug Prices Motley Fool
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Repatha to treat coronary artery diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism (sHPT); and Erenumab for the prevention of migraine. Its products also comprise Blincyto to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia; Kyprolis, a proteasome inhibitor for the treatment of multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; AMJEVITA to treat psoriatic arthritis and polyarticular juvenile idiopathic arthritis, as well as ankylosing spondylitis and rheumatoid arthritis; ABP 215 for biosimilar candidates; and ABP 980 to treat human epidermal growth factor receptor 2-positive early breast cancer. The company's marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells. It serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. The company has collaborative agreements with Pfizer Inc.; UCB; Bayer HealthCare Pharmaceuticals Inc.; Array BioPharma Inc.; Syngene International Limited; and CytomX Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Harper Sean EEVP, Research & DevelopmentOct 09Sale185.951,525283,57459,156Oct 10 08:29 PM
BALTIMORE DAVIDDirectorMay 31Sale153.933,700569,54131,159Jun 02 07:21 PM
Patton Cynthia MSVP & CCOMay 24Sale154.402,922451,16421,292May 24 07:35 PM
UNP Union Pacific Corporation daily Stock Chart
UNP [NYSE]
Union Pacific Corporation
IndexS&P 500 P/E20.34 EPS (ttm)5.51 Insider Own0.10% Shs Outstand810.44M Perf Week-1.57%
Market Cap90.84B Forward P/E17.40 EPS next Y6.44 Insider Trans-2.13% Shs Float799.70M Perf Month-1.16%
Income4.52B PEG1.57 EPS next Q1.49 Inst Own81.10% Short Float1.31% Perf Quarter2.60%
Sales20.72B P/S4.38 EPS this Y-7.70% Inst Trans-0.06% Short Ratio3.13 Perf Half Y5.51%
Book/sh24.39 P/B4.60 EPS next Y11.90% ROA8.00% Target Price120.43 Perf Year15.75%
Cash/sh1.70 P/C66.02 EPS next 5Y12.92% ROE22.70% 52W Range87.06 - 116.93 Perf YTD8.11%
Dividend2.42 P/FCF44.95 EPS past 5Y8.60% ROI13.60% 52W High-5.62% Beta0.87
Dividend %2.16% Quick Ratio0.90 Sales past 5Y0.40% Gross Margin80.70% 52W Low26.76% ATR1.39
Employees42162 Current Ratio1.10 Sales Q/Q10.10% Oper. Margin37.30% RSI (14)41.13 Volatility1.25% 1.13%
OptionableYes Debt/Eq0.80 EPS Q/Q24.20% Profit Margin21.80% Rel Volume0.97 Prev Close112.09
ShortableYes LT Debt/Eq0.78 EarningsOct 26 BMO Payout41.70% Avg Volume3.35M Price110.36
Recom2.40 SMA20-3.54% SMA501.06% SMA2002.22% Volume2,585,804 Change-1.54%
Oct-04-17Downgrade Citigroup Buy → Neutral
Oct-02-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-21-17Downgrade Deutsche Bank Buy → Hold
Apr-28-17Reiterated Cowen Market Perform $109 → $117
Mar-14-17Initiated Wells Fargo Market Perform
Jan-20-17Reiterated RBC Capital Mkts Sector Perform $111 → $115
Jan-20-17Reiterated Cowen Market Perform $98 → $109
Jan-18-17Initiated Buckingham Research Neutral
Jan-09-17Upgrade Barclays Equal Weight → Overweight $104 → $122
Nov-02-16Initiated Deutsche Bank Buy $110
Oct-24-16Initiated Seaport Global Securities Buy $100
Oct-21-16Downgrade RBC Capital Mkts Outperform → Sector Perform $107 → $98
Oct-20-16Downgrade Cowen Outperform → Market Perform $99 → $91
Jul-20-16Downgrade Deutsche Bank Buy → Hold $94
Jun-03-16Upgrade Morgan Stanley Equal-Weight → Overweight $90
May-19-16Initiated Credit Agricole Sell
Apr-22-16Reiterated RBC Capital Mkts Outperform $90 → $95
Apr-18-16Downgrade UBS Buy → Neutral $89 → $88
Feb-23-16Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-22-16Upgrade BofA/Merrill Neutral → Buy
Oct-16-17 07:40AM  Behind BNSF Railways Freight Traffic Growth Last Week Market Realist
Oct-13-17 01:43PM  What Caused Union Pacifics Railcar Volume Decline Last Week? Market Realist
09:52AM  What's in Store for Canadian Pacific (CP) in Q3 Earnings? Zacks
Oct-12-17 10:37AM  What Analysts Recommend for CSX ahead of 3Q17 Earnings Market Realist
08:00AM  See what the IHS Markit Score report has to say about Union Pacific Corp. Markit
Oct-11-17 10:49AM  How CSX Stock Has Performed This Year Market Realist
09:38AM  Here's What You Can Expect From Big Railroads in Q3 Earnings Zacks
08:44AM  What's in the Offing for J.B. Hunt (JBHT) in Q3 Earnings? Zacks
Oct-10-17 08:00AM  See what the IHS Markit Score report has to say about Union Pacific Corp. Markit
Oct-09-17 10:39AM  What Led Union Pacifics Volume Fall Last Week? Market Realist
Oct-06-17 07:27PM  David Herro's 3rd Quarter 2017 Global Fund Commentary GuruFocus.com
Oct-05-17 02:48PM  Union Pacific Announces Finance Department Appointments; Mary Jones' and Pat O'Malley's Retirements PR Newswire
Oct-04-17 06:36PM  Cramer reveals the market's top 10 actionable negatives CNBC Videos
06:17PM  Market's top 10 actionable negatives CNBC Videos
09:40AM  Yahoo Finance Live: Midday Movers - Oct 4th, 2017 Yahoo Finance Video
09:22AM  A Railroad Pair Trade: Kansas City Southern Vs. Union Pacific Benzinga
09:00AM  3 Stocks to Hold for the Next 30 Years Motley Fool
Oct-02-17 02:39PM  Riding The Rails: Canadian Train Stocks Preferred To CSX, Union Pacific Benzinga
07:41AM  Inside BNSF Railways Freight Volumes in Week 38 Market Realist
Sep-29-17 05:17PM  Is Union Pacific Corporations (UNP) 22.55% ROE Good Enough Compared To Its Industry? Simply Wall St.
02:06PM  Behind Union Pacifics Freight Volume Growth in Week 38 Market Realist
10:42AM  Are Class I Railroads Actions Indicating Trouble Ahead? Market Realist
09:14AM  Why You Should Pay Attention to US Class I Railroads Stock Buybacks Market Realist
07:42AM  Reading US Class I Railroads Recent Stock Buybacks Market Realist
Sep-28-17 02:15PM  How US Railroad Stocks Have Fared after Their 2Q17 Earnings Results Market Realist
08:00AM  Union Pacific Corporation Invites You to Join Its 3rd Quarter 2017 Earnings Release Broadcast PR Newswire
Sep-26-17 03:37PM  Will Railroads Shine Brightly Despite Headwinds in Q3? Zacks
11:06AM  BNSF Railway: Volume Growth Was Higher Than Industrys in Week 37 Market Realist
11:06AM  This Train Stock With 2% Dividend Is Rolling Into Buy Range Investor's Business Daily
09:21AM  Union Pacific: Which Commodities Led the Volume Slump in Week 37? Market Realist
08:00AM  See what the IHS Markit Score report has to say about Union Pacific Corp. Markit
Sep-22-17 09:49AM  Union Pacific Corp. : UNP-US: Dividend Analysis : August 31st, 2017 (record date) : By the numbers : September 22, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Union Pacific Corp. Markit
Sep-21-17 04:13PM  Stocks Close Lower; Breakouts In Industrial Giants Share A Common Flaw Investor's Business Daily
03:13PM  Union Pacific Celebrates Rail Safety Week in Communities PR Newswire
09:30AM  Can CSX Catch Up to the Other Rails? TheStreet.com
09:08AM  Why Union Pacific Consolidated Its Sales and Marketing Division Market Realist
07:38AM  Analysts Post-Hurricane Views on US Railroads Market Realist
Sep-20-17 09:09AM  Analyzing Hurricane Harveys Impact on Union Pacific Market Realist
08:07AM  How US Class I Railroad Stocks Have Fared since the Hurricanes Market Realist
07:50AM  Featured Company News - Union Pacific Redesigns Marketing & Sales Organization; Set to Align with Evolving Customer Needs ACCESSWIRE
07:38AM  Trends behind Genesee & Wyomings European Carloads in August 2017 Market Realist
Sep-19-17 10:38AM  Why Kansas City Southerns Freight Volumes Fell in Week 36 Market Realist
08:28AM  Union Pacific Streamlines Operations to Improve Efficiency Zacks
08:08AM  Union Pacific: Intermodal Rise Limits Fall in Railcars in Week 36 Market Realist
Sep-18-17 04:36PM  Canadian National Railway: Freight Growth Continued in Week 36 Market Realist
11:09AM  One of Warren Buffetts favorite industries is about to get hot again: MKM MarketWatch
09:31AM  Here's Why Hold is a Better Option for Union Pacific Stock Zacks
09:07AM  This US Railroad Had Highest Dividend Yield after 2Q17 Earnings Market Realist
08:00AM  See what the IHS Markit Score report has to say about Union Pacific Corp. Markit
07:38AM  Gauging FedExs Capital Expenditure in Fiscal 2018 Market Realist
Sep-15-17 07:16PM  Union Pacific Redesigns Marketing & Sales Organization to Align with Evolving Customer Needs PR Newswire
05:46PM  Top Research Reports for Philip Morris, Amgen & Union Pacific Zacks
Sep-14-17 10:39AM  Which US Railroad Posted Highest Intermodal Revenue Growth in 2Q17? Market Realist
Sep-13-17 04:38PM  How Major US Railroads Have Performed in 2017 So Far Market Realist
08:00AM  See what the IHS Markit Score report has to say about Union Pacific Corp. Markit
Sep-12-17 08:42PM  Union Pacific Corp. Value Analysis (NYSE:UNP) : September 13, 2017 Capital Cube
Sep-11-17 09:34AM  Union Pacific Corp. breached its 50 day moving average in a Bullish Manner : UNP-US : September 11, 2017 Capital Cube
07:37AM  Union Pacific: Has Hurricane Harvey Impacted Freight Volumes? Market Realist
Sep-08-17 10:56AM  Week 35: Hurricane Harvey Halted US Rail Freight Volumes Growth Market Realist
Sep-07-17 03:18PM  U.S. freight movers rethink how to guard against floods Reuters
01:52PM  U.S. freight movers rethink how to guard against floods Reuters
Sep-06-17 06:41PM  Union Pacific CEO sees pent-up demand in Harvey recovery Reuters
12:29PM  Harvey has 'paralyzed' a critical part of US manufacturing supply chain CNBC
08:00AM  See what the IHS Markit Score report has to say about Union Pacific Corp. Markit
Sep-05-17 09:02PM  The 6 Best Dividend Stocks in the Railroad Industry Motley Fool
Sep-04-17 09:07AM  Kansas City Southern: What Led Volume Rise in Week 34? Market Realist
Sep-02-17 05:30PM  Union Pacific says Arkema chemical plant fire hindering line repairs Reuters
Sep-01-17 03:06PM  Union Pacific: What Led to the Decline in Freight Volumes in Week 34? Market Realist
Aug-31-17 08:25PM  Top U.S. railroads resume limited operations in storm-hit Texas Reuters
05:13PM  4 Dividend-Paying Railroad Stocks Your Portfolio Must Have Zacks
04:08PM  Union Pacific says repairs completed on some lines out of Houston Reuters
03:03PM  Union Pacific says repairs completed on lines out of Houston Reuters
Aug-30-17 08:43PM  Harvey may cause long-term disruption on Houston's rail tracks Reuters
07:39PM  Harvey may cause long-term disruption on Houston's rail tracks Reuters
01:13PM  Union Pacific eyes Houston clean-up, inspecting damaged track Reuters
12:23PM  Railroads warn of long closure of Houston-area tracks Reuters
08:01AM  See what the IHS Markit Score report has to say about Union Pacific Corp. Markit
08:00AM  Union Pacific Corporation CFO Rob Knight to Address the Cowen and Company 10th Annual Global Transportation Conference PR Newswire
Aug-29-17 04:26PM  Union Pacific re-routing rail freight between Mexico, Texas Reuters
12:21PM  Harvey's impact on the trucking industry CNBC Videos
09:08AM  How Berkshires BNSF Could Benefit from Trumps Manufacturing Push Market Realist
09:07AM  Kansas City Southern: Behind the Freight Volume Rise in Week 33 Market Realist
Aug-28-17 07:52PM  Union Pacific Railroad Donating $250,000 for Hurricane Harvey Relief PR Newswire
04:44PM  Harvey hits U.S. fuel supplies to Latin America Reuters
03:36PM  CSX: Intermodal Pushed Volumes despite Fall in Railcars in Week 33 Market Realist
02:06PM  Comparing Union Pacifics Freight Volumes with the Industry in Week 33 Market Realist
07:00AM  Harvey hits U.S. fuel supplies to Latin America Reuters
Aug-27-17 06:28PM  Harvey hits U.S. fuel supplies to Latin America Reuters
Aug-24-17 03:43PM  3 Railroads to Buy on Coal Comeback & Other Catalysts Zacks
07:36AM  Genesee and Wyoming Saw Dive in European Carloads in July 2017 Market Realist
Aug-23-17 03:59PM  Stephanie Link: why I bought Oracle, Cummins & Union Pacific CNBC
01:53PM  Stephanie Link's new buys CNBC Videos
01:01PM  Midnight CSX trains arent going anywhere Yahoo Finance Video
09:07AM  Kansas City Southern: Did Coal Push Volumes in Week 32? Market Realist
07:37AM  How Union Pacifics Freight Rail Volumes Fared in Week 32 Market Realist
Aug-22-17 05:35PM  CSXs Intermodal Volumes Rose as Railcar Volumes Fell in Week 32 Market Realist
02:32PM  Week 32: US Freight Rail Traffic Remains on Elevated Tracks Market Realist
10:32AM  CSX Corp. Outperforms Its Peers, but Is That Enough? Motley Fool
08:00AM  See what the IHS Markit Score report has to say about Union Pacific Corp. Markit
Union Pacific Corporation, through its subsidiary, Union Pacific Railroad Company, operates railroads in the United States. It offers transportation services for agricultural products, including grains, commodities produced from grains, and food and beverage products; automotive products, such as finished vehicles and automotive parts; and chemicals comprising industrial chemicals, plastics, fertilizers, petroleum and liquid petroleum gases, crude oil, and soda ash. The company also provides transportation services for coal, petroleum coke, and biomass; industrial products consisting of construction products, minerals, consumer goods, metals, lumber, paper, and other miscellaneous products; and intermodal import and export container traffic. Its rail network includes 32,070 route miles linking the Pacific Coast and Gulf Coast ports with the Midwest and Eastern United States gateways. Union Pacific Corporation was founded in 1862 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Whited Elizabeth FEVP & CHIEF MARKETING OFFICERJul 21Option Exercise31.192,00062,38051,583Jul 24 02:47 PM
Scott Cameron AEVP & CHIEF OPERATING OFFICERJul 07Option Exercise75.5217,6041,329,45495,470Jul 10 01:09 PM
Scott Cameron AEVP & CHIEF OPERATING OFFICERJul 07Sale107.6017,6041,894,19077,866Jul 10 01:09 PM
Whited Elizabeth FEVP & CHIEF MARKETING OFFICERMar 10Option Exercise31.191,00031,19050,583Mar 13 11:36 AM
Whited Elizabeth FEVP & CHIEF MARKETING OFFICERMar 10Sale106.891,000106,89049,583Mar 13 11:36 AM
Card Andrew H JRDirectorJan 25Option Exercise24.257,400179,45022,400Jan 26 10:44 AM
Card Andrew H JRDirectorJan 25Sale109.534,000438,12918,400Jan 26 10:44 AM
BUTLER ERIC LEVP & CHIEF ADMIN OFFICERDec 09Option Exercise39.1327,0681,059,287234,784Dec 12 03:30 PM
MCCONNELL MICHAEL WDirectorDec 09Option Exercise24.257,400179,45026,410Dec 12 10:56 AM
BUTLER ERIC LEVP & CHIEF ADMIN OFFICERDec 09Sale104.9423,1982,434,398222,062Dec 12 03:30 PM
MCCONNELL MICHAEL WDirectorDec 09Sale105.157,400778,11919,010Dec 12 10:56 AM
ROGEL STEVEN RDirectorNov 22Option Exercise24.257,400179,45011,400Nov 23 10:51 AM
ROGEL STEVEN RDirectorNov 22Sale100.517,400743,7474,000Nov 23 10:51 AM
DUREN DIANE KEVP CHIEF ADMIN OFFICER & CORPNov 18Sale98.982,840281,103128,701Nov 21 02:14 PM
BIIB Biogen Inc. daily Stock Chart
BIIB [NASD]
Biogen Inc.
IndexS&P 500 P/E22.04 EPS (ttm)15.23 Insider Own0.10% Shs Outstand211.90M Perf Week2.03%
Market Cap71.13B Forward P/E14.47 EPS next Y23.20 Insider Trans32.15% Shs Float210.64M Perf Month4.49%
Income3.29B PEG3.34 EPS next Q5.70 Inst Own90.90% Short Float1.55% Perf Quarter18.78%
Sales11.72B P/S6.07 EPS this Y10.30% Inst Trans0.01% Short Ratio2.58 Perf Half Y23.79%
Book/sh54.67 P/B6.14 EPS next Y7.60% ROA15.00% Target Price336.41 Perf Year25.45%
Cash/sh13.65 P/C24.59 EPS next 5Y6.59% ROE27.80% 52W Range244.28 - 344.37 Perf YTD28.51%
Dividend- P/FCF19.32 EPS past 5Y27.40% ROI21.00% 52W High0.38% Beta0.72
Dividend %- Quick Ratio1.80 Sales past 5Y17.80% Gross Margin86.80% 52W Low41.52% ATR6.70
Employees7400 Current Ratio2.10 Sales Q/Q6.40% Oper. Margin38.70% RSI (14)77.65 Volatility1.87% 1.92%
OptionableYes Debt/Eq0.56 EPS Q/Q-15.00% Profit Margin28.10% Rel Volume1.15 Prev Close335.68
ShortableYes LT Debt/Eq0.51 EarningsOct 24 BMO Payout0.00% Avg Volume1.26M Price345.70
Recom2.20 SMA207.27% SMA5011.58% SMA20022.94% Volume1,160,957 Change2.98%
Oct-17-17Upgrade Stifel Hold → Buy $300 → $415
Oct-17-17Upgrade Mizuho Neutral → Buy $319 → $400
Oct-05-17Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-21-17Downgrade Raymond James Strong Buy → Mkt Perform
Sep-20-17Initiated SunTrust Buy $360
Sep-15-17Initiated RBC Capital Mkts Sector Perform $319
Jul-26-17Upgrade Goldman Neutral → Buy
Jul-11-17Resumed Jefferies Hold
Jun-23-17Initiated Deutsche Bank Buy $315
Jun-19-17Upgrade UBS Sell → Neutral $262 → $270
Mar-16-17Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-16-17Downgrade Leerink Partners Outperform → Mkt Perform
Mar-02-17Initiated Instinet Buy $345
Feb-07-17Upgrade Citigroup Neutral → Buy
Dec-29-16Reiterated Raymond James Strong Buy $375 → $386
Dec-09-16Reiterated Stifel Hold $291 → $298
Nov-08-16Initiated Mizuho Buy $290
Nov-07-16Upgrade Piper Jaffray Neutral → Overweight
Nov-07-16Upgrade Leerink Partners Mkt Perform → Outperform
Sep-06-16Downgrade Jefferies Buy → Hold
Oct-17-17 11:55AM  Biogen Biomarkers Mark Way To Alzheimer's, Parkinson's Treatments Investor's Business Daily
11:51AM  Should You Expect Biogen Inc (BIIB) To Continue Delivering An ROE Of 28.62%? Simply Wall St.
07:32AM  3 Drug Stocks Hitting 52-Week Highs: Are They Buys? Motley Fool
Oct-16-17 12:01PM  [$$] More Biotechs That Can Beat Q3 Views Barrons.com
08:01AM  6 Top Biotech Companies In Innovation Earn Recognition In New Awards Investor's Business Daily
Oct-13-17 05:25PM  It's Friday the 13th, and these are 4 freaky good stocks ... CNBC Videos
11:40AM  This No. 1-Ranked Medical Stock Is Breaking Out With Q3 Earnings Due Investor's Business Daily
11:18AM  Can Biotech Stay Healthy Through the End of 2017? Barrons.com
Oct-12-17 06:00AM  Celgene, Biogen Are Poised to Break Out: A Technical View Investopedia
Oct-11-17 08:07AM  Biotech Stock Roundup: Amgen's Imlygic Data Promising, Regeneron Scores Win in PCSK9 Lawsuit Zacks
Oct-10-17 10:01AM  5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings Zacks
07:37AM  Better Buy: Biogen Inc. vs. Celgene Motley Fool
Oct-09-17 09:13AM  How Did Biogen Perform in 1H17? Market Realist
08:04AM  See what the IHS Markit Score report has to say about Biogen Inc. Markit
07:43AM  Analysts Recommendations for Biogen in October 2017 Market Realist
Oct-06-17 01:20PM  Bernstein analyst breaks down his best biotech picks CNBC Videos
01:06PM  Why Biogen and L Brands Rose on October 5 Market Realist
11:09AM  Life (Science) Lessons: The Hows And Whos To Play Biotech Benzinga
09:37AM  No Side Effects to This Bullish Trade on Celgene Corporation (CELG) Stock InvestorPlace
07:59AM  [$$] Get Back Into Biogen Barrons.com
Oct-05-17 03:30PM  Netflix Breaks Out While Homebuilders Add To Rally Investor's Business Daily
01:29PM  Biotech: Buy Biogen, Sell Celgene Barrons.com
11:59AM  Celgene and Biogen Analyst Moves Are 'Useless,' Jim Cramer Says TheStreet.com
11:47AM  Catabasis' DMD Candidate Slows Disease Progression, Stock Up Zacks
11:45AM  3 Biotechs to Buy Ahead of Q3 Earnings Barrons.com
11:19AM  US STOCKS-Tech stocks power Wall St indexes to fresh record-highs Reuters
10:35AM  Biogen shares jump after Morgan Stanley upgrades company on its Alzheimers drugs CNBC
09:55AM  Cramer's Stop Trading: Celgene is not a sell CNBC Videos
09:53AM  Biogen's stock surges after Morgan Stanley boosts rating, price target MarketWatch
09:41AM  Nasdaq Leads Stocks Higher; Microsoft, Biogen Upgraded Investor's Business Daily
07:30AM  Biogens SPINRAZA® (nusinersen) Data Show Earlier Treatment Initiation May Lead to Improved Motor Function Across a Broad Population of People Living with Spinal Muscular Atrophy Business Wire
Oct-04-17 04:11PM  How Mylan's MS-Generic Approval Caused Teva, Momenta To Plunge Investor's Business Daily
02:00PM  Why Biotech's Rally May Push These 8 Stocks Even Higher Investopedia
12:11PM  Emergent Completes Acquisition of Anthrax Drug Raxibacumab Zacks
09:11AM  Amgen Enters Into an Immuno-Oncology Partnership With CytomX Zacks
08:03AM  Zacks.com featured highlights include article Texas Instruments, Applied Materials, Pepsico, CBRE Group and Biogen Zacks
07:54AM  After Strong Q3, Vetr Issues Hold Downgrade On Biogen Benzinga
Oct-03-17 09:53AM  After Intepirdine Flunked in Alzheimers Disease, Is Axovant Sciences a Buy? Motley Fool
09:50AM  Allergan's sNDA for Anti-Infective Avycaz Accepted by FDA Zacks
09:30AM  3 Top-Ranked Big Biotech Stocks to Buy Now Zacks
08:19AM  The Zacks Analyst Blog Highlights: Procter & Gamble, PetroChina, Biogen, Accenture and Norfolk Southern Zacks
Oct-02-17 06:19PM  Lilly (LLY) Makes Leadership Changes to Executive Positions Zacks
05:25PM  Top Stock Reports for Procter & Gamble, PetroChina & Biogen Zacks
04:56PM  Top Stock Reports for Procter & Gamble, PetroChina & Biogen Zacks
Oct-01-17 05:11PM  Congressman urges President Trump to take action on $90,000 multiple sclerosis drug MarketWatch
Sep-29-17 01:24PM  Biotech stocks plunge after FDA makes it easier for public to search for drug side effects CNBC
12:43PM  Biogen: Shares Hit By Similar Fears Hitting Sarepta; Analyst Calls Pullback "Inappropriate" Barrons.com
12:39PM  FDA makes side effect database searchable CNBC Videos
Sep-27-17 08:04AM  See what the IHS Markit Score report has to say about Biogen Inc. Markit
Sep-26-17 04:01PM  Biogen to Report Third Quarter 2017 Financial Results on October 24, 2017 Business Wire
08:04AM  See what the IHS Markit Score report has to say about Biogen Inc. Markit
Sep-25-17 09:40AM  Is Biogen Inc. (BIIB) a Great Stock for Value Investors? Zacks
09:23AM  Biogen Appoints Camille Lee as SVP, Alzheimers Disease Therapeutic Area Business Wire
Sep-22-17 08:10AM  Today's Research Reports on Stocks to Watch: Juno Therapeutics and Biogen ACCESSWIRE
06:00AM  Gilead, Amgen, and Biogen May Lift Biotech Higher Investopedia
Sep-21-17 11:22AM  Today's charts: Tesla, AMD developing new AI chip; Blue Apron shares gain; Biogen downgrade; Amazon expands in New York Yahoo Finance
11:09AM  Biogen: Buy or Hold? Barrons.com
11:03AM  Today's charts: Tesla, AMD developing new AI chip; Blue Apron shares gain; Biogen drops on downgrade Yahoo Finance Video
09:25AM  Morning Movers: Calgon Carbon Surges, Biogen Slips, AMD Gains Barrons.com
09:06AM  Biogen's stock falls after Raymond James cuts rating by two notches MarketWatch
08:04AM  See what the IHS Markit Score report has to say about Biogen Inc. Markit
Sep-20-17 10:51AM  Biogen Spinoff Bioverativ Is A Buy Benzinga
08:04AM  See what the IHS Markit Score report has to say about Biogen Inc. Markit
Sep-19-17 10:41AM  Profit From the Biogen Inc (BIIB) Stock Dip! InvestorPlace
07:01AM  Apple Leads 7 Top Stocks Holding In Buy Range Investor's Business Daily
Sep-18-17 11:35AM  Gilead Sciences: Is The Kite Deal Too Little, Too Late? Barrons.com
Sep-16-17 08:03AM  Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020? Motley Fool
Sep-14-17 05:01PM  Biosimilar 2017 Progress Report: Stocks in Focus Zacks
Sep-13-17 10:05AM  4 Biotech Stocks for the Long-Term InvestorPlace
Sep-12-17 08:49AM  What Is Biogen Incs (BIIB) Share Price Doing? Simply Wall St.
08:06AM  See what the IHS Markit Score report has to say about Biogen Inc. Markit
07:30AM  Biogen Appoints Sanjay Jariwala as SVP, Worldwide Medical Business Wire
Sep-11-17 10:10AM  See what the IHS Markit Score report has to say about Biogen Inc. Markit
09:33AM  Why Biogen Stock Raced Higher In August Motley Fool
08:36AM  Whats Gilead Sciences Valuation? Market Realist
Sep-08-17 10:22AM  See what the IHS Markit Score report has to say about Biogen Inc. Markit
Sep-07-17 05:52PM  Despite biotech's epic run, these names are still a barga... CNBC Videos
Sep-06-17 04:01PM  Biogen to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Business Wire
Sep-01-17 07:45AM  These 4 Biotechs Just Moved Into Buy Zones; Is This Giant Next? Investor's Business Daily
07:00AM  Featured Company News - Ionis Earns Regulatory Milestone Payment from Biogen for SPINRAZA ACCESSWIRE
Aug-29-17 11:29AM  Biogen Alzheimer's Drug Shows Promise in Long-Term Study Zacks
08:03AM  See what the IHS Markit Score report has to say about Biogen Inc. Markit
07:38AM  Trade of the Day: Biogen Inc (BIIB) Stock Is Coiling InvestorPlace
07:00AM  S&P 500 Futures Fall Sharply On North Korea Launch Investor's Business Daily
Aug-28-17 04:35PM  Biogen's Alzheimer's Drug Shows Promise Could It Break Out? Investor's Business Daily
10:35AM  Head of Biogen's copycat drug unit leaves to join Scangos startup American City Business Journals
08:02AM  See what the IHS Markit Score report has to say about Biogen Inc. Markit
07:40AM  Featured Company News - IMRALDI(R), Biogen's Version of AbbVie's Humira(R), Approved in the European Union ACCESSWIRE
07:30AM  Biogen Reports New Data from Phase 1b Study of Investigational Alzheimers Disease Treatment Aducanumab Business Wire
Aug-27-17 08:01AM  Consider This Before You Buy Biogen Motley Fool
Aug-25-17 11:13AM  Biogen's Humira Biosimilar Imraldi Gets Approval in EU Zacks
12:00AM  Samsung, Biogen version of AbbVie's Humira approved in Europe Reuters
Aug-24-17 08:57PM  Samsung, Biogen version of AbbVie's Humira approved in Europe Reuters
07:05PM  IMRALDI®, Biogens Adalimumab Biosimilar Referencing Humira®, is Approved in the European Union Business Wire
09:07AM  How Ioniss Spinraza Performed in 2Q17 Market Realist
Aug-23-17 06:06PM  Ionis Reports Revenue Growth in 2Q17 Market Realist
03:42PM  Here's the Simple Reason Why Multiple Sclerosis Drugs Cost So Much Motley Fool
07:56AM  Biotech Stock Roundup: EU Label Expansion for Alexion, BIIB Facing Drug Price Probe Zacks
07:37AM  How Allergans International Segment Performed in 2Q17 Market Realist
Aug-22-17 05:29PM  ETF Topper: Biotechnology Isn't Totally on the Outs Barrons.com
Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies. The company's Phase III clinical trial products comprise GAZYVA for the treatment of front-line indolent non-hodgkin's lymphoma; and Aducanumab and E2609 for Alzheimer's disease. Its Phase II clinical trial products include BIIB074 for trigeminal neuralgia, lumbosacral radiculopathy, and erythromelalgia; BAN2401 for Alzheimer's disease; Opicinumab (anti-LINGO-1) for MS; TYSABRI for acute ischemic stroke; rAAV-XLRS for X-linked juvenile retinoschisis; BG00011 (STX-100) for idiopathic pulmonary fibrosis; and Dapirolizumab pegol and BIIB059 (Anti-BDCA02) for lupus. The company's Phase I clinical trial products comprise BIIB061 for MS; BIIB054 for Parkinson's disease; BIIB067 (IONIS-SOD1Rx) for amyotrophic lateral sclerosis; and BIIB068 (BTK Inhibitor) for autoimmune disease. It has collaboration agreements with AbbVie, Inc.; Acorda Therapeutics, Inc.; Applied Genetic Technologies Corporation; Eisai Co., Ltd.; Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and University of Pennsylvania. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & SecJul 25Sale290.014,9741,442,51022,258Jul 26 04:22 PM
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & SecJul 19Sale285.007,7582,211,03027,232Jul 20 05:00 PM
Posner Brian SDirectorJun 09Sale256.311,084277,8406,330Jun 12 04:29 PM
Ehlers Michael DEVP, Research and DevelopmentJun 01Option Exercise0.001,25904,027Jun 05 04:38 PM
Vounatsos MichelChief Executive OfficerMay 02Option Exercise0.001,73604,663May 04 04:16 PM
Vounatsos MichelChief Executive OfficerMay 01Buy271.351,402380,4332,927May 02 04:18 PM
DENNER ALEXANDER JDirectorApr 27Buy278.5073,85820,569,476383,858May 01 05:47 PM
Clancy Paul JExecutive VP and CFOApr 25Sale290.009,8922,868,68010,813Apr 27 04:23 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratApr 03Sale274.081,981542,9527,060Apr 04 04:18 PM
Clancy Paul JExecutive VP and CFOMar 13Sale291.559,8912,883,72120,705Mar 14 07:32 PM
McKenzie PaulEVP Pharmaceutical Oper & TechMar 01Option Exercise0.004810718Mar 03 06:07 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratMar 01Sale290.07973282,2389,041Mar 03 06:02 PM
Clancy Paul JExecutive VP and CFOFeb 28Option Exercise0.006,780031,948Mar 02 05:24 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 28Option Exercise0.004,785010,398Mar 02 05:22 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 28Option Exercise0.005,559036,024Mar 02 05:20 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 28Option Exercise0.0068104,508Mar 02 05:18 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffFeb 28Option Exercise0.002,06409,237Mar 02 05:16 PM
DiPietro KennethEVP Human ResourcesFeb 28Option Exercise0.005,69608,260Mar 02 05:12 PM
Vounatsos MichelChief Executive OfficerFeb 27Buy285.391,333380,4251,434Mar 01 04:18 PM
PANGIA ROBERT WDirectorJan 09Option Exercise52.225,450284,59922,078Jan 10 04:15 PM
PANGIA ROBERT WDirectorJan 09Sale295.395,4501,609,87616,628Jan 10 04:15 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffDec 01Sale296.534814,2337,360Dec 05 04:34 PM
UNH UnitedHealth Group Incorporated daily Stock Chart
UNH [NYSE]
UnitedHealth Group Incorporated
IndexDJIA S&P500 P/E23.23 EPS (ttm)8.32 Insider Own0.50% Shs Outstand968.87M Perf Week-1.58%
Market Cap187.19B Forward P/E17.81 EPS next Y10.85 Insider Trans-3.08% Shs Float951.74M Perf Month-2.51%
Income8.11B PEG1.56 EPS next Q2.56 Inst Own89.10% Short Float0.87% Perf Quarter3.40%
Sales192.60B P/S0.97 EPS this Y20.60% Inst Trans-0.09% Short Ratio3.05 Perf Half Y14.60%
Book/sh44.77 P/B4.32 EPS next Y9.86% ROA6.20% Target Price211.22 Perf Year44.27%
Cash/sh15.05 P/C12.84 EPS next 5Y14.90% ROE20.10% 52W Range133.03 - 200.76 Perf YTD20.72%
Dividend3.00 P/FCF18.54 EPS past 5Y8.90% ROI11.40% 52W High2.10% Beta0.64
Dividend %1.55% Quick Ratio- Sales past 5Y12.70% Gross Margin- 52W Low54.09% ATR3.03
Employees230000 Current Ratio- Sales Q/Q7.70% Oper. Margin7.20% RSI (14)68.03 Volatility1.74% 1.62%
OptionableYes Debt/Eq0.74 EPS Q/Q27.80% Profit Margin4.20% Rel Volume2.89 Prev Close193.20
ShortableYes LT Debt/Eq0.61 EarningsOct 17 BMO Payout30.90% Avg Volume2.73M Price204.98
Recom1.50 SMA204.93% SMA504.77% SMA20014.87% Volume6,261,234 Change6.10%
Jul-19-17Reiterated Mizuho Buy $200 → $235
Jun-07-17Initiated Morgan Stanley Overweight
Apr-18-17Reiterated Mizuho Buy $178 → $200
Apr-05-17Initiated Deutsche Bank Buy $183
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Upgrade Cantor Fitzgerald Hold → Buy
Nov-30-16Upgrade Mizuho Neutral → Buy $178
Nov-30-16Reiterated RBC Capital Mkts Outperform $168 → $175
Nov-09-16Downgrade Mizuho Buy → Neutral
Oct-19-16Reiterated Mizuho Buy $160 → $169
Jul-22-16Upgrade Argus Hold → Buy
Jul-20-16Reiterated RBC Capital Mkts Outperform $157 → $165
Jul-19-16Reiterated Mizuho Buy $156 → $160
Jun-16-16Initiated Bernstein Outperform
Jun-13-16Reiterated Mizuho Buy $156 → $156
Apr-20-16Reiterated Mizuho Buy $150 → $156
Apr-19-16Reiterated FBR Capital Outperform $130 → $145
Mar-15-16Reiterated Mizuho Buy $131 → $150
Dec-16-15Initiated Credit Suisse Outperform
Nov-20-15Reiterated Mizuho Buy $155 → $131
Oct-17-17 02:18PM  New leadership and earnings beat propel unprecedented UnitedHealth stock move MarketWatch +6.10%
01:27PM  Stocks Sputter While Facebook Climbs Past Its Buy Point Investor's Business Daily
01:20PM  UnitedHealth weighs in on Trump order, Amazon, as earnings jump American City Business Journals
01:17PM  Nike among today's IQ100 leaders CNBC Videos
01:15PM  Healthcare Drives Small Gains for Dow While Rest of Market Slips TheStreet.com
12:29PM  UnitedHealth Group Inc (UNH) Stock Surges on Q3 Earnings Report InvestorPlace
12:02PM  [$$] UnitedHealth Revenue Grows Despite ACA Exit The Wall Street Journal
11:58AM  Stock Indexes Up Slightly; Trump Threatens Drug Firms Investor's Business Daily
11:50AM  UnitedHealth and J&J Drive Dow to 23,000 but Rest of Market Wavers TheStreet.com
11:33AM  UnitedHealth sees growth in 2018, a year of changes by Trump Reuters
11:13AM  UnitedHealth beats 3Q forecasts, helped by Optum growth Associated Press
11:07AM  UnitedHealth and Johnson & Johnson Lead Bruised Healthcare Sector to Gains TheStreet.com
11:00AM  UnitedHealth Profits Jump, Raises EPS Estimate 24/7 Wall St.
10:57AM  UnitedHealth Signals Openness To Amazon Partnership; Earnings Beat Investor's Business Daily
10:49AM  UnitedHealth (UNH) Beats Q3 Earnings on Higher Membership Zacks
10:44AM  UnitedHealth's stock heads toward biggest price rise in its 33-year history MarketWatch
10:40AM  Health-care ETF rallies, boosted by UnitedHealth and J&J results MarketWatch
10:18AM  Stocks Go Green, But Banks Mixed; Facebook Breaks Out Investor's Business Daily
10:06AM  UnitedHealth, J&J stock rallies keeping Dow positive while Goldman drags MarketWatch
09:43AM  UnitedHealth: Welcome to the Party, Mr. Wichmann Barrons.com
09:31AM  UnitedHealth sets 2018 forecast at current consensus Reuters
09:30AM  UnitedHealth Group's Optum Growth Overcomes Costly Obamacare Exit Forbes
09:24AM  Stocks to Watch: Goldman Sachs, Morgan Stanley, Netflix, J&J, UnitedHealth, Snap, Facebook The Wall Street Journal
09:23AM  UnitedHealth sets 2018 forecast at current consensus Reuters
09:14AM  Goldman, Morgan Stanley Gain on Earnings; Spirit Airlines Flies Barrons.com
08:14AM  Stock Futures Mixed as Wall Street Digests Morgan Stanley, Goldman Earnings TheStreet.com
08:12AM  Stocks making the biggest moves premarket: UNH, MS, JNJ, HOG, CMA, NFLX & more CNBC
07:46AM  NFL Owners Meet Today, UnitedHealth Beats: Tuesday's Top Stories TheStreet.com
07:05AM  UnitedHealth Group reports Q3 earnings beat, revenue miss MarketWatch
06:41AM  UnitedHealth tops profit estimate on growth across businesses CNBC
06:32AM  UnitedHealth (UNH) Beats on Q3 Earnings, Guides Higher Zacks
06:08AM  UnitedHealth tops profit estimate on growth across businesses Reuters
06:00AM  UnitedHealth beats 3Q profit forecasts Associated Press
05:55AM  UnitedHealth Group Third Quarter Highlights Business Wire
05:42AM  Insurer UnitedHealth's profit rises 26.3 pct Reuters
05:23AM  UnitedHealth earnings: Insulated from Obamacare, Amazon and still going strong MarketWatch
Oct-16-17 01:03PM  Trump's Decision To Cut Cost-Sharing Subsidies Hurt UnitedHealth And 4 Other Health Care Stocks Forbes
08:30AM  Is a Surprise Coming for UnitedHealth Group (UNH) This Earnings Season? Zacks
Oct-15-17 03:42PM  Wounded Veterans to Cycle from San Francisco to Los Angeles During 450-Mile UnitedHealthcare California Challenge Business Wire
Oct-14-17 07:49PM  Sorry Everybody, But Trump Hasn't Instigated The Obamacare Apocalypse Forbes
Oct-13-17 06:47PM  Cramer looks at pivotal earnings week CNBC Videos
06:39PM  Cramer's game plan: A pivotal earnings week CNBC Videos
06:11PM  Cramer's game plan: A pivotal earnings week CNBC
02:50PM  U.S. drops lawsuit against UnitedHealth after losing court ruling Reuters
10:29AM  Haunted Healthcare? Trump ACA Decision Hits Hospitals, Insurers Barrons.com
08:42AM  UnitedHealth (UNH) Q3 Earnings Likely to Beat: Here's Why? Zacks
Oct-12-17 04:13PM  Dow ends lower, retreats from records as Goldman, UnitedHealth weigh MarketWatch
04:01PM  Disney, Verizon Sink DJIA Thursday 24/7 Wall St.
10:00AM  Catalyst Health Network and UnitedHealthcares Accountable Care Organization Fostering High-Quality Care at Lower Cost Business Wire
Oct-11-17 10:00AM  UnitedHealthcare Awards $120,000 in Grants to Five Community Organizations in Michigan Business Wire
08:22AM  UnitedHealth Group, Inc. breached its 50 day moving average in a Bearish Manner : UNH-US : October 11, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about UnitedHealth Group Inc. Markit
Oct-10-17 09:40AM  UnitedHealth plans to sell employer coverage in Minnesota American City Business Journals
09:37AM  Will Dow ETFs Continue to Shine in Q3 Earnings? Zacks
09:00AM  Military Health System Beneficiaries to Receive Global Nurse Advice Line Services from Optum Business Wire
08:00AM  See what the IHS Markit Score report has to say about UnitedHealth Group Inc. Markit
06:32AM  2 Big Safe Havens if the Stock Rally Crashes Investopedia
Oct-09-17 04:01PM  General Electric, Nike Sink DJIA on Monday 24/7 Wall St.
03:11PM  4 HMOS for Gains Amid Constant Regulatory Chaos Zacks
08:00AM  See what the IHS Markit Score report has to say about UnitedHealth Group Inc. Markit
Oct-08-17 10:48AM  202 Million Americans Disapprove of Republicans' Handling of Healthcare Reform, Survey Shows Motley Fool
Oct-07-17 03:06PM  UnitedHealthcare and Optum Take Action to Support People Affected by Tropical Storm Nate Business Wire
Oct-06-17 01:00PM  U.S. suffers setback in lawsuit against UnitedHealth Reuters
09:51AM  S&P 500 Breaks 20-Year Record: 5 Best Buys Zacks
08:00AM  See what the IHS Markit Score report has to say about UnitedHealth Group Inc. Markit
Oct-05-17 06:12PM  Cramer breaks down the Dow's top 10 drivers from last quarter CNBC
11:00AM  More Americans Turn to Technology to Help Evaluate and Access Health Care; Health Literacy Remains a Challenge for Some Consumers Business Wire
10:49AM  Stock Market News For Oct 5, 2017 Zacks
09:41AM  5 of the Best Blue-Chip Dividend Stocks to Buy in October Zacks
07:00AM  Hospitals Brace For Unpaid Bills If GOP Balks On Children's Healthcare Forbes
Oct-04-17 04:01PM  Nike, Caterpillar Underpin DJIA on Wednesday 24/7 Wall St.
11:43AM  Mednax (MD) Acquires Urology Unit, Deepens Reach in Florida Zacks
Oct-03-17 03:44PM  Exact Sciences: GoingUp! Barrons.com
02:30PM  7 Dividend Powerhouses That Beat The S&P Investopedia
10:38AM  4 Top Performers From Health Insurance Industry in Q3 Zacks
Oct-02-17 02:00PM  Spiros Segalas Picks Up 5 New Stocks in 3rd Quarter GuruFocus.com
09:00AM  UnitedHealthcares 2018 Medicare Plans Offer Strong Value Business Wire
08:43AM  Dow stocks like Disney, Home Depot rally in the fourth quarter more than 80% of the time CNBC
Sep-29-17 01:23PM  UnitedHealthcare Opens New Health Benefits Store in Palisades Park Business Wire
09:49AM  What Confusion About Health Insurance Looks Like In The Doctor's Office Forbes
08:28AM  Could Tax Reform Boost the Healthcare Sector? Market Realist
Sep-28-17 04:01PM  McDonalds, Exxon Mobil Prop Up DJIA on Thursday 24/7 Wall St.
10:40AM  Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Centene, Magellan Health and WellCare HealthPlans Zacks
09:45AM  UnitedHealth Group, Inc. : UNH-US: Dividend Analysis : September 08th, 2017 (record date) : By the numbers : September 28, 2017 Capital Cube
09:35AM  Anthem Grows on Membership, Public Exchange Woes Hurt Zacks
Sep-27-17 03:00AM  Stocks With Rising Relative Strength: Molina Healthcare Investor's Business Daily
Sep-26-17 06:58PM  New England Patriots and UnitedHealthcare Build a Playground for Bridge Boston Charter School Business Wire
06:17PM  Demographic Changes, Diversification Aid Health Insurers Zacks
04:01PM  Apple, American Express Buoy DJIA on Tuesday 24/7 Wall St.
11:28AM  UnitedHealth Group, Inc. Value Analysis (NYSE:UNH) : September 26, 2017 Capital Cube
06:50AM  UnitedHealth Group Schedules Third Quarter Earnings Release and Conference Call for October 17, 2017 Business Wire
06:37AM  Zacks Industry Outlook Highlights: Triple-S Management, Anthem, UnitedHealth Group and Select Medical Holdings Zacks
Sep-25-17 06:18PM  Volunteers from Los Angeles Dodgers and UnitedHealthcare Unveil New Walking Path at Allesandro Elementary School Business Wire
03:41PM  Health Insurance Industry Stock Outlook - Sept. 2017 Zacks
12:49PM  Stock Market News For Sep 25, 2017 Zacks
10:57AM  Stocks close lower after tech slide, North Korea threats CNBC
08:18AM  UnitedHealth Group, Inc. breached its 50 day moving average in a Bearish Manner : UNH-US : September 25, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about UnitedHealth Group Inc. Markit
Sep-24-17 09:18AM  Could This Be Warren Buffett's Greatest Weakness? Motley Fool
Sep-22-17 04:14PM  Markets Right Now: Stocks end mostly higher Associated Press
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company's UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, individuals, and military service members; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services. It also provides services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; and health services, including commercial health and dental benefits. This segment serves through a network of 1 million physicians and other health care professionals, as well as approximately 6,000 hospitals and other facilities. Its OptumHealth segment offers health management services, including care delivery and management, wellness and consumer engagement, distribution, and health financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The company's OptumInsight segment provides software and information products, and business process outsourcing and support services to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. Its OptumRx segment offers pharmacy care services and programs, including retail network contracting, home delivery and specialty pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BURKE RICHARD TDirectorSep 25Option Exercise48.106,090292,9111,825,072Sep 26 04:42 PM
RENFRO LARRY CVice Chmn, UHG and CEO, OptumSep 15Sale198.1150,57410,019,428195,625Sep 18 04:39 PM
WILENSKY GAIL RDirectorSep 05Option Exercise48.115,600269,44060,834Sep 07 04:43 PM
WILENSKY GAIL RDirectorSep 05Sale199.495,6001,117,11755,834Sep 07 04:43 PM
BURKE RICHARD TDirectorAug 21Sale191.7115,0002,875,6261,818,898Aug 22 05:10 PM
BALLARD WILLIAM C JRDirectorAug 03Option Exercise56.675,000283,35076,058Aug 04 04:46 PM
BALLARD WILLIAM C JRDirectorAug 03Sale193.985,000969,91571,058Aug 04 04:46 PM
BURKE RICHARD TDirectorJul 21Option Exercise48.431,08052,3041,833,898Jul 25 04:42 PM
BURKE RICHARD TDirectorJun 27Option Exercise52.225,000261,1001,832,583Jun 28 04:20 PM
BALLARD WILLIAM C JRDirectorJun 07Option Exercise48.145,000240,70075,735Jun 08 04:21 PM
BALLARD WILLIAM C JRDirectorJun 07Sale182.645,000913,21170,735Jun 08 04:21 PM
WILENSKY GAIL RDirectorJun 02Option Exercise51.855,540287,25260,516Jun 06 05:06 PM
WILENSKY GAIL RDirectorJun 02Sale178.745,540990,22755,516Jun 06 05:06 PM
BURKE RICHARD TDirectorMay 24Option Exercise54.5796052,3871,827,495May 25 04:47 PM
BURKE RICHARD TDirectorMay 04Sale173.1947,5008,226,7201,829,035May 08 04:49 PM
WICHMANN DAVID SPresidentApr 24Option Exercise54.41175,0009,521,750800,316Apr 25 04:53 PM
BALLARD WILLIAM C JRDirectorApr 20Option Exercise52.225,000261,10075,735Apr 21 04:37 PM
BALLARD WILLIAM C JRDirectorApr 20Sale170.475,000852,32570,735Apr 21 04:37 PM
WILSON D ELLENEVP Human CapitalApr 19Sale170.5414,0002,387,61031,993Apr 21 04:39 PM
Shine Kenneth IrwinDirectorApr 19Sale169.12838141,71828,528Apr 21 04:38 PM
BURKE RICHARD TDirectorMar 27Option Exercise53.735,000268,6501,876,270Mar 29 05:50 PM
HOOPER MICHELE JDirectorMar 16Option Exercise39.5215,000592,75035,941Mar 20 04:50 PM
HOOPER MICHELE JDirectorMar 16Sale170.8915,0002,563,34530,941Mar 20 04:50 PM
DARRETTA ROBERT JDirectorMar 15Option Exercise54.0216,621897,94955,134Mar 16 05:02 PM
BURKE RICHARD TDirectorMar 02Sale167.4850,0008,373,9251,871,191Mar 06 04:52 PM
WILENSKY GAIL RDirectorFeb 23Option Exercise53.785,310285,56760,175Feb 24 04:42 PM
WILENSKY GAIL RDirectorFeb 23Sale162.315,310861,88555,175Feb 24 04:42 PM
BALLARD WILLIAM C JRDirectorFeb 14Option Exercise53.735,000268,65075,391Feb 15 04:50 PM
BALLARD WILLIAM C JRDirectorFeb 14Sale162.685,000813,40070,391Feb 15 04:50 PM
BURKE RICHARD TDirectorJan 31Sale161.6810,0001,616,7501,921,191Feb 02 05:28 PM
BURKE RICHARD TDirectorJan 23Option Exercise52.2189046,4671,931,191Jan 25 04:17 PM
BURKE RICHARD TDirectorDec 29Option Exercise52.575,000262,8501,930,030Jan 03 04:34 PM
Bueno Edson de GodoyDirectorDec 21Option Exercise55.0357,2003,147,716207,817Dec 22 08:55 PM
BURKE RICHARD TDirectorDec 15Sale159.8015,0002,397,0001,925,030Dec 15 04:36 PM
BURKE RICHARD TDirectorDec 08Sale158.6645,0007,139,4891,944,949Dec 09 04:09 PM
ROOS THOMAS EChief Accounting OfficerDec 06Sale157.602,000315,20321,083Dec 08 04:24 PM
WILENSKY GAIL RDirectorNov 17Option Exercise52.545,460286,86760,512Nov 21 04:10 PM
WILENSKY GAIL RDirectorNov 17Sale150.555,460822,00055,052Nov 21 04:10 PM
BALLARD WILLIAM C JRDirectorNov 14Sale151.213,000453,61570,039Nov 16 04:22 PM
WILSON D ELLENEVP Human CapitalOct 21Option Exercise46.1816,275751,58066,635Oct 25 05:07 PM
Shine Kenneth IrwinDirectorOct 21Sale144.9932547,12128,613Oct 25 05:08 PM
WILSON D ELLENEVP Human CapitalOct 21Sale144.1814,3652,071,10552,270Oct 25 05:07 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E23.34 EPS (ttm)1.13 Insider Own32.21% Shs Outstand2.17B Perf Week-0.27%
Market Cap57.16B Forward P/E17.54 EPS next Y1.50 Insider Trans0.00% Shs Float1.46B Perf Month0.84%
Income2.69B PEG4.02 EPS next Q0.32 Inst Own38.20% Short Float1.95% Perf Quarter-4.77%
Sales26.33B P/S2.17 EPS this Y-20.90% Inst Trans0.09% Short Ratio6.06 Perf Half Y-5.86%
Book/sh10.57 P/B2.49 EPS next Y12.10% ROA5.20% Target Price32.25 Perf Year-2.08%
Cash/sh0.03 P/C947.95 EPS next 5Y5.80% ROE12.10% 52W Range24.01 - 30.25 Perf YTD-2.63%
Dividend1.68 P/FCF- EPS past 5Y-3.30% ROI7.80% 52W High-13.79% Beta0.92
Dividend %6.38% Quick Ratio0.40 Sales past 5Y-12.30% Gross Margin13.60% 52W Low8.61% ATR0.32
Employees6800 Current Ratio0.60 Sales Q/Q17.60% Oper. Margin14.40% RSI (14)48.34 Volatility1.29% 1.31%
OptionableYes Debt/Eq1.03 EPS Q/Q13.70% Profit Margin10.20% Rel Volume0.65 Prev Close26.33
ShortableYes LT Debt/Eq0.88 EarningsOct 26 BMO Payout128.30% Avg Volume4.70M Price26.08
Recom1.60 SMA20-0.60% SMA500.27% SMA200-3.79% Volume2,445,683 Change-0.96%
Oct-10-17Initiated Seaport Global Securities Neutral $29
Sep-01-17Reiterated Jefferies Buy $33 → $30
Jun-15-17Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-18-17Initiated Guggenheim Buy
Jan-31-17Reiterated Barclays Overweight $31 → $33
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Oct-17-17 07:50AM  Kinder Morgan Underperformed Its Peers Last Week Market Realist
Oct-14-17 11:34AM  2 High Yield Dividend Investing Tips That Could Earn You Thousands Motley Fool
Oct-13-17 01:06PM  Why Did Enterprise Products Increase Its 3Q17 Distribution? Market Realist
11:23AM  Enterprise Products Partners Raised 3Q17 Distributions 0.6% Market Realist
11:09AM  Enterprise Sets a New Pace For Pipelines: Slow Bloomberg
10:11AM  Stock Market News For Oct 13, 2017 Zacks
09:18AM  Enterprise Products (EPD) Hikes Quarterly Cash Distribution Zacks
06:04AM  3 Stocks for an Approaching Bear Market Motley Fool
Oct-12-17 04:11PM  Enterprise Declares Quarterly Distribution Increase Business Wire
Oct-11-17 09:47AM  Did Kinder Morgan Inc. Just Put Enterprise Products Partners' Latest Growth Project on Ice? Motley Fool
Oct-10-17 02:55PM  Colonial partners with Enterprise for fuel exports from Beaumont terminal Reuters
07:39AM  What Does Enbridge Energy Partners Valuation Indicate? Market Realist
Oct-09-17 09:11AM  Short Interest in Enbridge Energy Partners Has Risen 17% Recently Market Realist
Oct-07-17 08:12AM  3 Stocks that Pay You to Own Them Motley Fool
Oct-04-17 02:16PM  Kinder Morgan Inc. Gets the Green Light to Keep Growing Motley Fool
09:12AM  Proposed Tax Plan: MLPs Should Benefit from Expensing Provision Market Realist
08:33AM  Better Buy: Enterprise Products Partners LP vs. Buckeye Partners, L.P. Motley Fool
07:43AM  Why Enterprise Products Partners Is in 4th Place among the Top 7 MLPs Market Realist
Oct-03-17 11:58AM  The Top 7 Analyst Favorite MLPs Market Realist
10:38AM  Energy Giants Are Stalking This Prey in Hopes of Bagging a Speedy New Growth Platform Motley Fool
Sep-30-17 12:23PM  3 Dividend Stocks I'd Buy Right Now Motley Fool
Sep-29-17 06:03AM  3 High-Yield Stocks for Building a Nest Egg Motley Fool
Sep-28-17 11:00AM  3 High-Yield Stocks With Virtual Monopolies Motley Fool
07:31AM  Better Buy: Magellan Midstream Partners, L.P. vs. Enterprise Products Partners LP Motley Fool
Sep-26-17 08:14AM  Enterprise Products Partners LP breached its 50 day moving average in a Bullish Manner : EPD-US : September 26, 2017 Capital Cube
08:13AM  3 High Dividend Yields That Are Here to Stay Motley Fool
Sep-25-17 05:36PM  Does Enterprise Products Partners Yield Indicate Undervaluation? Market Realist
04:36PM  Is Kinder Morgans Valuation Attractive? Market Realist
04:07PM  Enterprise Products Partners Maintains Strong Leverage Market Realist
02:19PM  A Look at Enterprise Products Partners Massive Spending Plans Market Realist
07:00AM  Oneok's Positioned to Outperform Morningstar
Sep-24-17 08:03AM  3 High-Yield Dividend Stocks to Buy This Fall Motley Fool
Sep-23-17 08:13AM  The 2 Safest High-Yield Dividend Stocks in Energy Motley Fool
Sep-22-17 11:38AM  ONEOK Has Risen 6% since It Acquired ONEOK Partners Market Realist
10:47AM  This High-Yield Partnership Could Offer Retirees Sustainable Income Motley Fool
07:17AM  3 High-Yield Dividend Giants Still Worth Owning Motley Fool
Sep-21-17 10:31AM  The 2 Biggest Reasons Enterprise Products Partners L.P. Is a Better Dividend Stock Than Kinder Morgan Inc Motley Fool
10:21AM  This 10.9% Yield Is Safer Than It May Seem Motley Fool
Sep-20-17 01:46PM  How Does Holly Energy Partners' High-Yield Partnership Hold Up to Enterprise Products Partners? Motley Fool
Sep-19-17 04:30PM  Enterprise Products to Participate in J.P. Morgan Midwest Energy Infrastructure / MLP Conference Business Wire
06:02AM  3 Growth Stocks for Nest-Egg Building Motley Fool
Sep-18-17 01:00PM  What Drove MLPs Performance Last Week Market Realist
Sep-16-17 10:32AM  Losing Sleep Over Your Dividend Portfolio? Consider This High-Yield Partnership Motley Fool
12:00AM  Enterprise says fire nearly out at Texas NGL complex Reuters
Sep-15-17 07:00PM  3 High-Yield Dividend Stocks for September Motley Fool
08:07AM  Is Enterprise Products Partners LP (EPD) A Buy At Its Current Price? Simply Wall St.
Sep-14-17 07:32AM  This Is the Real Reason to Love High-Yielding Magellan Midstream Partners, L.P. Motley Fool
Sep-13-17 04:15PM  Enterprise Enters into New Revolving Credit Facilities to Extend Maturities Business Wire
01:16PM  The 3 Dividend Stocks You'll Wish You'd Bought 10 Years From Now Motley Fool
Sep-12-17 11:06AM  Better Buy: Enterprise Products Partners L.P. vs. Magellan Midstream Partners, L.P. Motley Fool
07:38AM  What Analysts Recommend for Kinder Morgan Market Realist
Sep-11-17 04:04PM  Kinder Morgan Underperformed Peers Last Week Market Realist
07:37AM  What Does WMBs Current Valuation Indicate? Market Realist
07:03AM  Better Dividend Buy: Enterprise Products Partners L.P. vs. Kinder Morgan, Inc. Motley Fool
Sep-08-17 10:37AM  Williams Companies Stock Trends and Technical Indicators Market Realist
Sep-07-17 04:11PM  6 MLPs With Sustainable Yields of 6% or More Barrons.com
06:35AM  Independent Oil & Gas Stock Performance Review -- Enbridge Energy Management, Enterprise Products Partners, EP Energy, and Resolute Energy PR Newswire
Sep-06-17 10:52AM  Why Kinder Morgan Inc. Shares Fell 5% in August, Lagging Its Midstream Peers Motley Fool
Sep-05-17 06:00PM  3 High-Yield Stocks Motley Fool
02:06PM  What Does Kinder Morgans Valuation Indicate? Market Realist
11:36AM  My 3 Biggest Stock Holdings Motley Fool
08:00AM  Enterprise Resumes Service at Substantially All of Its Major Assets Business Wire
07:00AM  Enterprise Products to Participate in Barclays CEO EnergyPower Conference Business Wire
Sep-04-17 05:00AM  Enterprise Products (EPD) Down 2.8% Since Earnings Report: Can It Rebound? Zacks
Sep-01-17 10:44AM  Enterprise Products Reports Minor Damages in Texas Plants Zacks
08:19AM  In Your 60s? 3 Stocks You Should Consider Buying Motley Fool
07:36AM  EPD, ETP, WPZ, and MMP: What Lies ahead for the MLP Giants Market Realist
Aug-31-17 06:17PM  ETFs with exposure to Enterprise Products Partners LP : August 31, 2017 Capital Cube
01:15PM  Enterprise Evaluating Potential Curtailment of Mont Belvieu NGL Fractionation & Storage Services Business Wire
10:36AM  How Energy Transfer Partners Valuation Stacks Up with Peers Market Realist
09:06AM  Short Interest in Enterprise Products and Magellan Rose Recently Market Realist
07:37AM  ETP and EPD: Are Institutional Investors Bullish? Market Realist
Aug-30-17 04:26PM  Center Coast MLP & Infrastructure Fund (CEN) Statement on Hurricane Harvey PR Newswire
04:02PM  Update: LyondellBasell shuts several Houston-area facilities, Motiva reduces refinery capacity American City Business Journals
02:14PM  Harvey's Winds and Rain Shut Down U.S. LPG Exports to Asia Bloomberg
11:51AM  Despite Harvey's Wrath, MLPs Prove Resilient --- So Far Barrons.com
11:14AM  Enterprise Products Plants Partly Operational Amid Harvey Zacks
11:09AM  BofA Merrill Lynch Adds Position in Enterprise Products Partners Market Realist
10:37AM  Why Williams Partners Plans to Spend More Capital in 2017 Market Realist
09:08AM  EPD, ETP, MMP, and WPZ: In-Depth Leverage Analysis Market Realist
08:26AM  Bullish on Kinder Morgan Inc? Then You'll Love These High-Yielding Stocks Motley Fool
07:37AM  Whats Been Driving Magellan Midstream Partners Market Realist
Aug-29-17 06:06PM  EPD, ETP, WPZ, and MMP: Analyzing Distributable Cash Flow Growth Market Realist
05:30PM  3 High-Yield Stocks on Sale Motley Fool
04:29PM  Why Williams Partners Outperformed Peers Year-to-Date Market Realist
02:30PM  Enterprise Products Partners LP : EPD-US: Dividend Analysis : July 31st, 2017 (record date) : By the numbers : August 29, 2017 Capital Cube
12:09PM  Hurricane Harvey Impacted Energy MLPs Market Realist
12:09PM  MLPs Recovered Slightly in the Week Ending August 25 Market Realist
07:37AM  Energy Transfer Partners Mainly Received Buy Ratings Market Realist
Aug-28-17 04:20PM  Enterprise Reports Initial Assessment of Impacts from Tropical Storm Harvey Business Wire
11:47AM  Forget Kinder Morgan, Inc.: These 2 Stocks Are Better High-Yield Buys Motley Fool
11:43AM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 28, 2017 Capital Cube
Aug-27-17 07:23AM  Forget Magellan Midstream Partners, L.P.: These 2 Stocks are Better Buys for Income Investors Motley Fool
Aug-26-17 10:23AM  2 Pipeline Stocks That Turned $3,000 Into More Than $39,000 Motley Fool
Aug-25-17 02:38PM  Enterprise shuts Shoup gas plant in Corpus Christi due to Harvey Reuters
Aug-23-17 01:29PM  Check These Masters Of The Energy Sector: 13 High-Yield MLPs Forbes
11:15AM  Enterprise Products Partners Not Showing Bottoming Signs, Yet TheStreet.com
Aug-22-17 03:35PM  Is It the Right Time Now to Buy MLPs? Market Realist
02:35PM  Recent Institutional Activity in Enterprise Products Partners Market Realist
02:32PM  Energy: Value play or value trap? CNBC Videos
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment offers natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,670 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas and ethane export terminals, and related operations. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 440 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,120 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 686 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates approximately 4,250 miles of refined products pipelines; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Edwin EAdvisory DirectorMar 06Sale28.0215,000420,300420,654Mar 06 05:18 PM
HACKETT JAMES TDirectorFeb 03Buy28.6533,000945,45033,000Feb 06 04:14 PM
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-11.66 Insider Own0.20% Shs Outstand335.20M Perf Week-2.23%
Market Cap66.51B Forward P/E11.29 EPS next Y17.58 Insider Trans-0.27% Shs Float333.57M Perf Month-9.93%
Income-3981.80M PEG- EPS next Q4.06 Inst Own86.10% Short Float2.03% Perf Quarter-19.26%
Sales15.07B P/S4.41 EPS this Y63.30% Inst Trans0.04% Short Ratio2.79 Perf Half Y-15.35%
Book/sh209.70 P/B0.95 EPS next Y8.47% ROA8.90% Target Price266.56 Perf Year-12.81%
Cash/sh17.38 P/C11.42 EPS next 5Y12.49% ROE15.70% 52W Range184.50 - 256.80 Perf YTD-5.52%
Dividend2.80 P/FCF261.12 EPS past 5Y-28.70% ROI0.10% 52W High-21.09% Beta1.16
Dividend %1.41% Quick Ratio1.10 Sales past 5Y26.00% Gross Margin87.10% 52W Low9.84% ATR5.78
Employees16700 Current Ratio1.20 Sales Q/Q8.80% Oper. Margin-20.80% RSI (14)40.99 Volatility2.99% 2.71%
OptionableYes Debt/Eq0.43 EPS Q/Q-88.00% Profit Margin77.30% Rel Volume1.46 Prev Close198.41
ShortableYes LT Debt/Eq0.38 EarningsNov 01 BMO Payout5.00% Avg Volume2.43M Price202.65
Recom2.10 SMA20-2.12% SMA50-7.66% SMA200-12.60% Volume2,819,719 Change2.14%
Oct-17-17Reiterated UBS Buy $275 → $255
Oct-02-17Reiterated Barclays Equal Weight
Sep-25-17Reiterated RBC Capital Mkts Outperform $285 → $277
Sep-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Oct-17-17 12:39PM  Here's How Drug Companies Game the Patent System Bloomberg
12:37PM  How Allergan's 'Public Relations Backlash' Deepened This Week Investor's Business Daily
10:07AM  Allergan Is the Cheapest Big-Cap Drug Stock in the Universe: Jim Cramer TheStreet.com
10:00AM  3 Dividend Healthcare Stocks Motley Fool
08:40AM  Today's Research Reports on Stocks to Watch: Allergan and Gilead Sciences ACCESSWIRE
07:10AM  Allergan patent suit loss sends stock down 4% MarketWatch
Oct-16-17 07:59PM  [$$] Allergan Loses Patent Fight in Federal Court The Wall Street Journal
04:42PM  Allergan Tanks After Judge Invalidates Restasis Patents Investor's Business Daily
04:11PM  [$$] Allergan Loses Patent Fight in Federal Court The Wall Street Journal
03:45PM  Allergan will repeal Restasis patent decision CNBC Videos
03:35PM  Allergan Loses a Patent BattleHas It Lost the War? Barrons.com
02:33PM  Allergan patent suit loss sends stock down 5% MarketWatch
01:45PM  U.S. judge in Texas invalidates Allergan patents on Restasis Reuters
01:45PM  U.S. District Court for the Eastern District of Texas Issues Adverse Trial Decision Concerning RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patents PR Newswire
01:42PM  Allergan stock drops 5% after judge decides against company on key dry eye product MarketWatch
01:21PM  Allergan's Restasis patents invalidated by federal judge CNBC Videos
01:18PM  U.S. judge in Texas invalidates Allergan patents on Restasis Reuters
08:01AM  Allergan to Present New Data at the World Congress of Gastroenterology at ACG 2017 PR Newswire
01:00AM  Allergan Update; Fixed Income: Doug Kass' Views TheStreet.com
12:17AM  [$$] Mylan Calls Allergans Patent Sale to Indian Tribe a Sham The Wall Street Journal
Oct-14-17 11:58AM  [$$] Mylan Calls Allergan's Patent Sale to Tribe a 'Sham' The Wall Street Journal
Oct-13-17 10:38AM  Trump to scrap a crucial part of Obamacare Yahoo Finance Video
08:06AM  Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Setback Zacks
06:05AM  3 Healthcare Value Stocks Motley Fool
Oct-12-17 06:45PM  Non-Alcoholic Steatohepatitis 2017 Progress Update Zacks
05:41PM  Allergan settles with one of four companies contesting Restasis patent Reuters
04:15PM  Allergan Announces Settlement on RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patent Litigation with InnoPharma, Inc. PR Newswire
10:30AM  Ardelyx IBS-C Candidate Succeeds in Pivotal Study, Stock Up Zacks
Oct-11-17 03:34PM  Allergan's Uterine Fibroids Candidate's NDA Accepted by FDA Zacks
09:45AM  Examining Consolidated Results on Allergan, Starbucks, Equifax, Walgreens, Texas Instruments, and Kraft Heinz Fundamental Analysis and Changes in Performance Indicators GlobeNewswire
08:01AM  Allergan to Present Data From More Than 20 Abstracts at the 2017 Fall Clinical Dermatology Conference PR Newswire
Oct-10-17 06:41PM  Health insurers, hospitals and generic-drug makers ask Congress to examine Allergan patent deal CNBC
05:22PM  Favorite stock picks from one of Wall Street's top biotech analysts CNBC
03:18PM  Allergan trading at a zero pipeline valuation: Evercore's... CNBC Videos
01:00PM  [$$] CVC Picks Former Allergan Executive to Run Women's Drug Portfolio The Wall Street Journal
08:01AM  Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids PR Newswire
03:19AM  'That should be illegal': Lawmakers are taking aim at pharma giant Allergan over an unusual deal with a Native American tribe Business Insider
Oct-09-17 03:56PM  Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result Benzinga
02:49PM  'That should be illegal': Lawmakers are taking aim at pharma giant Allergan over an unusual deal with a Native American tribe Business Insider
10:32AM  Valeant's Biggest Drug Gets a Shot at More Sales Barrons.com
08:30AM  Allergan to Present New Dry Eye Data at the American Academy of Optometry Meeting in Chicago PR Newswire
08:26AM  This billion-dollar dry eye drug is behind Allergans controversial patent deal MarketWatch
08:02AM  Rep. Peter Welch on Allergans bold, brazen, bizarre patent deal with an American Indian tribe MarketWatch
12:34AM  [$$] Reverse Patent Trolls Are Harming Drug Innovationand Patients The Wall Street Journal
Oct-08-17 07:12AM  [$$] Waxman hits out at Allergan patent deal with Mohawk tribe Financial Times
Oct-07-17 10:17AM  This billion-dollar dry eye drug is behind Allergans controversial patent deal MarketWatch
10:13AM  Rep. Peter Welch on Allergans bold, brazen, bizarre patent deal with an American Indian tribe MarketWatch
Oct-06-17 05:45PM  Judge asks if Allergan's patent deal with Mohawk tribe is a 'sham' CNBC
01:20PM  Bernstein analyst breaks down his best biotech picks CNBC Videos
11:00AM  Is Allergan plc a Bargain After a $7.6 Billion Dip in September? Motley Fool
09:07AM  Pharma Stock Roundup: Mylan Up, Teva Down on Copaxone News, Lawmakers Question Allergan Deal Zacks
Oct-05-17 10:54PM  'Nobody's talking about' 2 medical conditions that affect 8 million women in America but that could be about to change Business Insider
05:22PM  Senator McCaskill drafts bill in response to Allergan patent maneuver Reuters
12:05PM  Allergan Presents Data From Seventeen Abstracts At The 2017 American Society For Dermatologic Surgery Meeting In Chicago PR Newswire
11:45AM  3 Biotechs to Buy Ahead of Q3 Earnings Barrons.com
07:37AM  Changes in Eli Lillys Valuation Market Realist
06:03AM  3 Big Pharma Stocks Set to Succeed Motley Fool
Oct-04-17 11:40AM  Teva Shares Plummet After Mylan's Copaxone Generic Gets FDA Approval Zacks
09:45AM  6 Pharma Stocks to Buy Now Barrons.com
09:15AM  Allergan's Botox Gets FDA Nod for Forehead Line Treatment Zacks
08:01AM  Allergan To Present New Data From Its Anti-Infectives Portfolio At IDWeek 2017 In San Diego PR Newswire
Oct-03-17 04:43PM  U.S. House committee launches probe of Allergan patent deal Reuters
04:27PM  Drugmaker Under Fire For Using Mohawk Tribe To Shield Patent Investor's Business Daily
03:45PM  Allergan's unusual patent agreement CNBC Videos
01:23PM  Allergan Patent Deal May Hurt Competition, Lawmakers Say Bloomberg
12:53PM  Allergan CEO says patent review flawed in response to senators Reuters
10:19AM  [$$] Big Questions for Big Pharma Barrons.com
09:50AM  Allergan's sNDA for Anti-Infective Avycaz Accepted by FDA Zacks
09:45AM  Allergan responds to mounting criticism of Mohawk patent deal CNBC
07:37AM  Allergan's Botox gets FDA OK to treat forehead lines MarketWatch
07:31AM  FDA Approves BOTOX® Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines Associated with Frontalis Muscle Activity In Adults PR Newswire
01:04AM  Shire Alleges Allergan Blocked Drug From Medicare Contracts The Wall Street Journal
Oct-02-17 08:28PM  Markets Move Higher; Inversion Rules Put Pfizer-Allergan Back In Focus -- ICYMI TheStreet.com
06:31PM  More scrutiny for Allergan over Native American tribe deal CNBC
05:18PM  Senator questions Allergan deal CNBC Videos
04:40PM  [$$] Allergan leads drugmakers higher on repatriation hopes Financial Times
02:00PM  Shire Alleges Allergan Blocked Drug From Medicare Contracts The Wall Street Journal
01:31PM  Deere in high gear CNBC Videos
12:14PM  Shire sues Allergan in U.S. over dry eye drug Reuters
12:10PM  Shire sues Allergan in U.S. over dry eye drug Reuters
08:00AM  FDA Accepts Supplemental New Drug Application (sNDA) filing for AVYCAZ® (ceftazidime and avibactam) PR Newswire
07:30AM  Allergan to Report Third Quarter 2017 Earnings and Host Conference Call and Webcast PR Newswire
01:00AM  Allergan Price Target Reduction; Lacing Up Nike: Doug Kass' Views TheStreet.com
Sep-29-17 11:10PM  U.S. court strikes down Obama-era rule on tax inversions Reuters
09:20AM  Allergan (AGN) Pipeline & New Drugs to Counter Generic Woes Zacks
Sep-28-17 05:27PM  Tax reform could spark a wave of biopharma M&A CNBC Videos
09:23AM  Will Conatus Liver Disease Candidate Drive Long-Term Growth? Zacks
07:48AM  Allergans controversial patent agreement with an American Indian tribe is worrying investors MarketWatch
07:00AM  Healthcare: Stock Selection Key as Valuations Rise Morningstar
Sep-27-17 06:13PM  Senators want probe of Allergan transfer deal with tribe: letter Reuters
09:46AM  Axovant Rises After Tuesday's Plunge - Biotech Movers TheStreet.com
07:37AM  What Happened to Allergans Valuation after 2Q17? Market Realist
06:01AM  [$$] Allergan deal with Mohawk tribe casts patent shadow Financial Times
Sep-26-17 05:07PM  Allergan Authorizes New $2B Share Buyback Plan, Stock Up Zacks
05:06PM  Evening Sector Snapshot: Trucking Gains, Pharmaceuticals Slip Barrons.com
01:39PM  Drug companies ask Oklahoma judge to dismiss opioid lawsuit Associated Press
01:11PM  Allergan: Running Afoul of the Socially Responsible? Barrons.com
11:25AM  Is Teva Pharmaceutical (TEVA) Stock Worth the Risk? InvestorPlace
10:38AM  A Closer Look at Allergans International Business Market Realist
09:08AM  A Closer Look at Allergans US General Medicines Segment Market Realist
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOJun 16Buy235.964410,327131,178Sep 18 08:49 PM
Basgoz NesliDirectorMay 18Option Exercise84.441,889159,5077,919May 22 04:26 PM
Basgoz NesliDirectorMay 18Sale220.451,889416,4306,030May 22 04:26 PM
GALLAGHER MICHAEL RDirectorMay 04Option Exercise245.2517,6934,339,20820,272May 05 06:34 PM
SAUNDERS BRENT LChairman, President and CEOMar 29Buy242.214310,299131,135Sep 18 08:49 PM
BISARO PAULDirectorMar 02Sale246.6870,00017,267,561235,900Mar 06 06:59 AM
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
NSC Norfolk Southern Corporation daily Stock Chart
NSC [NYSE]
Norfolk Southern Corporation
IndexS&P 500 P/E21.28 EPS (ttm)6.10 Insider Own0.17% Shs Outstand292.65M Perf Week-0.76%
Market Cap37.99B Forward P/E18.37 EPS next Y7.07 Insider Trans-6.17% Shs Float287.70M Perf Month1.37%
Income1.80B PEG1.73 EPS next Q1.64 Inst Own72.30% Short Float1.30% Perf Quarter5.31%
Sales10.23B P/S3.71 EPS this Y10.30% Inst Trans-0.14% Short Ratio2.29 Perf Half Y15.02%
Book/sh43.81 P/B2.96 EPS next Y11.10% ROA5.20% Target Price129.39 Perf Year36.72%
Cash/sh2.19 P/C59.17 EPS next 5Y12.33% ROE14.40% 52W Range89.95 - 134.52 Perf YTD20.11%
Dividend2.44 P/FCF59.26 EPS past 5Y0.60% ROI9.50% 52W High-3.76% Beta1.36
Dividend %1.88% Quick Ratio0.70 Sales past 5Y-2.40% Gross Margin44.80% 52W Low43.92% ATR1.77
Employees28044 Current Ratio0.80 Sales Q/Q7.50% Oper. Margin31.70% RSI (14)51.35 Volatility1.68% 1.30%
OptionableYes Debt/Eq0.78 EPS Q/Q24.50% Profit Margin17.60% Rel Volume1.01 Prev Close129.80
ShortableYes LT Debt/Eq0.73 EarningsOct 25 BMO Payout39.00% Avg Volume1.63M Price129.46
Recom2.60 SMA20-1.25% SMA503.62% SMA2008.50% Volume1,307,481 Change-0.26%
Oct-16-17Downgrade Wells Fargo Outperform → Market Perform
Mar-23-17Downgrade RBC Capital Mkts Sector Perform → Underperform $113
Mar-14-17Initiated Wells Fargo Outperform
Jan-26-17Reiterated Cowen Outperform $116 → $130
Jan-18-17Initiated Buckingham Research Neutral
Jan-10-17Downgrade CLSA Outperform → Underperform
Jan-09-17Downgrade Seaport Global Securities Buy → Neutral $101 → $106
Nov-02-16Upgrade Argus Hold → Buy
Nov-02-16Initiated Deutsche Bank Buy $110
Oct-11-16Upgrade BofA/Merrill Neutral → Buy
Jun-03-16Resumed Morgan Stanley Underweight
May-19-16Initiated Credit Agricole Outperform
Apr-25-16Resumed JP Morgan Neutral
Apr-22-16Upgrade UBS Neutral → Buy $84 → $102
Apr-22-16Upgrade Credit Suisse Neutral → Outperform
Apr-22-16Reiterated Cowen Outperform $89 → $101
Apr-22-16Reiterated Barclays Equal Weight $88 → $90
Apr-13-16Resumed BofA/Merrill Neutral
Jan-28-16Upgrade Avondale Mkt Underperform → Mkt Perform
Jan-28-16Reiterated RBC Capital Mkts Sector Perform $84 → $74
Oct-17-17 11:08AM  CSX Q3 Earnings Meet, Rise Y/Y, Revenues Miss Estimates Zacks
Oct-13-17 03:36PM  Norfolk Southern: Freight Volumes Compared with the Industry in Week 40 Market Realist
09:52AM  What's in Store for Canadian Pacific (CP) in Q3 Earnings? Zacks
Oct-11-17 12:36PM  Will CSX Manage to Surpass Analysts Revenue Estimates in 3Q17? Market Realist
09:38AM  Here's What You Can Expect From Big Railroads in Q3 Earnings Zacks
Oct-09-17 09:12AM  Inside Norfolk Southerns Freight Volume Growth in Week 39 Market Realist
Oct-05-17 04:15PM  Norfolk Southern Names New CIO The Wall Street Journal
Oct-04-17 09:40AM  Yahoo Finance Live: Midday Movers - Oct 4th, 2017 Yahoo Finance Video
Oct-03-17 04:35PM  Norfolk Southern names Ehlers chief information officer PR Newswire
08:30AM  Norfolk Southern to hold third-quarter 2017 earnings conference call Oct. 25 PR Newswire
Oct-02-17 06:31PM  Norfolk Southern Rewards Investors, OK's New Buyback Plan Zacks
Sep-29-17 02:40PM  Norfolk Southern Is Rolling Right Along TheStreet.com
12:36PM  Inside Norfolk Southerns Freight Growth in Week 38 Market Realist
11:07AM  Should You Be Tempted To Buy Norfolk Southern Corporation (NSC) At Its Current Price? Simply Wall St.
10:42AM  Are Class I Railroads Actions Indicating Trouble Ahead? Market Realist
Sep-28-17 05:36PM  Does Norfolk Southern Have Enough Free Cash Flow to Support More Buybacks? Market Realist
04:07PM  Understanding Norfolk Southerns Buyback Strategy Market Realist
02:15PM  How US Railroad Stocks Have Fared after Their 2Q17 Earnings Results Market Realist
Sep-27-17 08:00AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Sep-26-17 10:31PM  Norfolk Southern increases stock repurchase program PR Newswire
03:37PM  Will Railroads Shine Brightly Despite Headwinds in Q3? Zacks
01:00PM  Norfolk Southern appoints Galanko, Scheib to new positions PR Newswire
11:06AM  Norfolk Southern: Why Freight Volumes Rose in Week 37 Market Realist
Sep-22-17 11:32AM  Transport Stocks Could Hit All-Time Highs Investopedia
08:01AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Sep-21-17 11:30AM  Norfolk Southern Foundation supports Hurricane Irma recovery efforts PR Newswire
08:01AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Sep-20-17 09:09AM  Analyzing Hurricane Harveys Impact on Union Pacific Market Realist
08:00AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Sep-19-17 09:10AM  Comparing BNSF Railways Freight Volumes with the Industry in Week 36 Market Realist
Sep-18-17 04:36PM  Norfolk Southern: Commodities Leading Shipment Rise in Week 36 Market Realist
Sep-14-17 09:09AM  This US Railroad Saw Highest Rise in Coal Revenue in 2Q17 Market Realist
08:08AM  Which US Railroad Saw Highest Revenue Growth in 2Q17? Market Realist
08:01AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Sep-13-17 04:38PM  How Major US Railroads Have Performed in 2017 So Far Market Realist
Sep-12-17 12:19PM  Norfolk Southern resumes limited trains service in Irma-hit areas Reuters
Sep-11-17 05:28PM  Norfolk Southern says rail traffic closed to ports in U.S. Southeast Reuters
09:07AM  BNSF Railway: Railcars Derailed, but Intermodal Grew in Week 35 Market Realist
Sep-08-17 02:06PM  CSX: A Deep Dive into Its Freight Volumes in Week 35 Market Realist
12:35PM  Norfolk Southern: How Volumes Compared to the Industry in Week 35 Market Realist
Sep-07-17 03:00AM  IBD Rating Upgrades: Norfolk Southern Flashes Improved Price Strength Investor's Business Daily
Sep-06-17 10:06AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Sep-05-17 09:02PM  The 6 Best Dividend Stocks in the Railroad Industry Motley Fool
08:01AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Sep-02-17 08:06AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Sep-01-17 11:52PM  Norfolk Southern Corp. Value Analysis (NYSE:NSC) : September 2, 2017 Capital Cube
05:01PM  Norfolk Southern Corp. : NSC-US: Dividend Analysis : August 07th, 2017 (record date) : By the numbers : September 1, 2017 Capital Cube
03:06PM  How Norfolk Southerns Freight Volumes Trended in Week 34 Market Realist
09:53AM  Norfolk Southern Foundation supports Hurricane Harvey recovery efforts PR Newswire
08:01AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Aug-30-17 08:43PM  Harvey may cause long-term disruption on Houston's rail tracks Reuters
07:39PM  Harvey may cause long-term disruption on Houston's rail tracks Reuters
12:23PM  Railroads warn of long closure of Houston-area tracks Reuters
08:45AM  Norfolk Southern Corp. breached its 50 day moving average in a Bullish Manner : NSC-US : August 30, 2017 Capital Cube
08:30AM  Norfolk Southern to present at Cowen and Company 10th Annual Global Transportation Conference PR Newswire
08:01AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Aug-29-17 08:01AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Aug-28-17 02:06PM  Norfolk Southern: What Drove Freight Volumes in Week 33? Market Realist
08:01AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Aug-24-17 03:43PM  3 Railroads to Buy on Coal Comeback & Other Catalysts Zacks
Aug-23-17 01:01PM  Midnight CSX trains arent going anywhere Yahoo Finance Video
11:53AM  How Genesee and Wyomings Volumes Trended in July 2017 Market Realist
Aug-22-17 04:06PM  How Norfolk Southerns Freight Rail Volumes Trended in Week 32 Market Realist
Aug-17-17 10:13AM  Norfolk Southern encourages eclipse viewers to be careful around railroad tracks PR Newswire
09:40AM  Should Value Investors Consider Norfolk Southern (NSC) Shares Now? Zacks
Aug-16-17 01:27PM  Norfolk Southern Promotes CIO Cynthia Earhart to CFO The Wall Street Journal
08:00AM  See what the IHS Markit Score report has to say about Norfolk Southern Corp. Markit
Aug-15-17 10:00AM  Norfolk Southern Corp. breached its 50 day moving average in a Bullish Manner : NSC-US : August 15, 2017 Capital Cube
Aug-14-17 04:27PM  Norfolk Southern Announces Pricing Of Previously Announced Exchange Offers, Interest Rate For New Notes And Acceptance Of Tendered Notes PR Newswire
04:05PM  Norfolk Southern appoints Cynthia C. Earhart executive vice president and chief financial officer PR Newswire
11:54AM  Zacks Industry Outlook Highlights: Union Pacific, CSX and Norfolk Southern Zacks
10:37AM  Burlington Northern Santa Fes Elevated Operating Margins in 2Q17 Market Realist
09:06AM  Higher Volumes and Burlington Northern Santa Fes Coal Revenues Market Realist
Aug-13-17 09:30AM  Edited Transcript of NSC earnings conference call or presentation 26-Jul-17 12:45pm GMT Thomson Reuters StreetEvents
Aug-11-17 07:35PM  Norfolk Southern Announces Expiration Of Early Exchange Period Of Previously Announced Exchange Offers And Increase In Aggregate Principal Amount Of New Notes To Be Issued To $750,000,000 PR Newswire
06:08PM  ETFs with exposure to Norfolk Southern Corp. : August 11, 2017 Capital Cube
03:48PM  Will Sluggish Automotive Production Derail Railroads? Zacks
10:53AM  Burlington Northern Santa Fe Ups Revenues by Volumes, Surcharge Market Realist
08:15AM  Zacks Industry Outlook Highlights: Union Pacific, Norfolk Southern, CSX, Kansas City Southern and Genesee & Wyoming Zacks
08:00AM  IHS Markit Score Update: Rise in demand for ETFs holding Norfolk Southern Corp is a positive for its shares Markit
Aug-10-17 05:57PM  Coal Revival: A Blessing for Railroads Zacks
10:53AM  Zacks Industry Outlook Highlights: CSX, Union Pacific, Kansas City Southern and Norfolk Southern Zacks
09:48AM  I Would Favor an Upside Breakout on Norfolk Southern TheStreet.com
Aug-09-17 03:54PM  Railroad Industry Stock Outlook - August 2017 Zacks
07:37AM  BNSF Railways Intermodal Supported Freight Growth in Week 30 Market Realist
Aug-08-17 08:10AM  Norfolk Southern: Railcars Derailed but Intermodal Rose Market Realist
Aug-07-17 09:35AM  Did Genesee & Wyoming Beat Its Own Revenue Guidance in 2Q17? Market Realist
07:59AM  Acquisitions Propel 2Q17 Earnings Growth for Genesee & Wyoming Market Realist
07:10AM  Earnings Review and Free Research Report: Norfolk Southern's Diluted EPS Soared 25.7% ACCESSWIRE
Aug-02-17 07:36AM  How Analysts View Norfolk Southern after Its 2Q17 Results Market Realist
07:30AM  Earnings Review and Free Research Report: Canadian National Railways Q2 Top-line Rose 17%; Beat Estimates ACCESSWIRE
Aug-01-17 10:39AM  Norfolk Southerns 2Q17 Operating Margins: Why the Elevated Track? Market Realist
09:10AM  Norfolk Southern: International Pushed Intermodal Revenues in 2Q17 Market Realist
07:40AM  Why NSCs General Merchandise Revenues Rose in 2Q17 Market Realist
07:37AM  Canadian National Railway: Inside the 2Q17 Rise in Grain Revenues Market Realist
Jul-31-17 04:35PM  Inside the Solid Rise of NSCs 2Q17 Coal Revenues Market Realist
03:05PM  Did Norfolk Southern Surpass Analysts Revenue Estimates in 2Q17? Market Realist
01:28PM  Norfolk Southern Beats 2Q17 Earnings, Increases Share Repurchases Market Realist
11:30AM  Dow rallies, Nasdaq falls as mega-mergers in focus Yahoo Finance
10:41AM  Canadian National Railway: Alberta Ups Petroleum Revenues Market Realist
Norfolk Southern Corporation, together with its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods in the United States. It also transports overseas freight through various Atlantic and Gulf Coast ports. In addition, the company is involved in the operation of scheduled passenger trains; leasing or sale of rail property and equipment; development of commercial real estate; telecommunications; and the acquisition, leasing, and management of coal, oil, gas, and minerals, as well as the transport of automotive and industrial products. As of February 14, 2017, it operated approximately 19,500 route miles in 22 states and the District of Columbia. The company was founded in 1883 and is based in Norfolk, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wheeler Michael JosephEVP & Chief Operating OfficerSep 20Option Exercise69.831,43299,99713,042Sep 22 10:33 AM
Hurlbut Thomas EVice President and ControllerAug 29Sale118.8030035,6404,000Aug 30 04:07 PM
Wheeler Michael JosephEVP & Chief Operating OfficerAug 25Option Exercise75.142,370178,08213,492Aug 28 12:37 PM
Wheeler Michael JosephEVP & Chief Operating OfficerAug 25Sale118.682,370281,27411,122Aug 28 12:37 PM
Squires James AChairman, President and CEOAug 15Option Exercise47.7624,4071,165,67876,481Aug 16 02:22 PM
Squires James AChairman, President and CEOAug 15Sale119.9524,4072,927,62052,074Aug 16 02:22 PM
STEWART MARTA REVP-Finance and CFOMay 26Sale121.982,093255,30415,633May 31 04:30 PM
Hurlbut Thomas EVice President and ControllerMay 25Sale116.5480293,4654,300May 30 02:30 PM
Hurlbut Thomas EVice President and ControllerMay 12Sale116.921,427166,8395,102May 15 04:12 PM
LOCKHART MICHAEL DDirectorMay 05Sale116.851743,732May 16 12:07 PM
Galanko William AndrewSVP - Law and Corp. Comm.May 04Sale116.78115515,580May 08 02:00 PM
BOWLES ERSKINE BDirectorMay 01Sale117.65023,477May 03 03:32 PM
BUSH WESLEY GDirectorMay 01Sale117.650233,389May 03 03:30 PM
Hurlbut Thomas EVice President and ControllerApr 28Sale117.6657167,1846,529May 01 01:30 PM
STEWART MARTA REVP-Finance and CFOFeb 21Sale124.432,331290,04616,156Feb 23 08:02 AM
Hurlbut Thomas EVice President and ControllerFeb 17Option Exercise56.182,836159,3189,877Feb 21 01:46 PM
Hurlbut Thomas EVice President and ControllerFeb 17Sale122.371,475180,4907,100Feb 21 01:46 PM
STEWART MARTA REVP-Finance and CFOFeb 13Option Exercise75.142,370178,08220,857Feb 15 01:52 PM
STEWART MARTA REVP-Finance and CFOFeb 13Sale123.072,370291,67618,487Feb 15 01:52 PM
STEWART MARTA REVP-Finance and CFOFeb 09Option Exercise62.752,607163,57621,094Feb 10 10:57 AM
STEWART MARTA REVP-Finance and CFOFeb 09Sale121.972,607317,97618,487Feb 10 10:57 AM
Galanko William AndrewSVP - Law and Corp. Comm.Feb 06Option Exercise47.765,000238,80023,107Feb 08 09:02 AM
Galanko William AndrewSVP - Law and Corp. Comm.Feb 06Sale119.135,934706,91716,337Feb 08 09:02 AM
STEWART MARTA REVP-Finance and CFOFeb 03Option Exercise47.762,907138,83821,394Feb 06 03:34 PM
Hurlbut Thomas EVice President and ControllerFeb 03Sale120.651,297156,4777,041Feb 06 03:34 PM
STEWART MARTA REVP-Finance and CFOFeb 03Sale120.502,907350,29418,487Feb 06 03:34 PM
BOWLES ERSKINE BDirectorFeb 02Sale119.120133,475Feb 06 03:34 PM
CARP DANIEL ADirectorFeb 02Sale119.120533,886Feb 06 03:34 PM
LOCKHART MICHAEL DDirectorFeb 02Sale119.120193,729Feb 06 03:34 PM
THOMPSON JOHN RDirectorFeb 02Sale119.120163,144Feb 06 03:34 PM
BUSH WESLEY GDirectorFeb 02Sale119.1211183,387Feb 07 11:36 AM
Hurlbut Thomas EVice President and ControllerFeb 01Option Exercise47.7660728,9908,945Feb 03 05:17 PM
Hurlbut Thomas EVice President and ControllerFeb 01Sale118.2660771,7848,338Feb 03 05:17 PM
Squires James AChairman, President and CEOJan 26Option Exercise35.6037,4171,332,11095,709Jan 30 04:30 PM
STEWART MARTA REVP-Finance and CFOJan 26Option Exercise0.00950020,898Jan 30 04:32 PM
Wheeler Michael JosephEVP & Chief Operating OfficerJan 26Option Exercise0.00950012,046Jan 30 04:32 PM
Earhart Cynthia CExec. VP - Admin. and CIOJan 26Option Exercise0.0095005,813Jan 30 04:30 PM
Galanko William AndrewSVP - Law and Corp. Comm.Jan 26Option Exercise0.00950018,848Jan 30 04:30 PM
Hurlbut Thomas EVice President and ControllerJan 26Option Exercise0.0095009,083Jan 30 04:30 PM
Shaw Alan H.EVP & Chief Marketing OfficerJan 26Option Exercise0.0055004,264Jan 30 04:30 PM
Squires James AChairman, President and CEOJan 26Sale119.7734,4174,122,29354,589Jan 30 04:30 PM
Hurlbut Thomas EVice President and ControllerNov 18Sale103.7746948,6677,041Nov 21 03:03 PM
Shaw Alan H.EVP & Chief Marketing OfficerNov 16Option Exercise47.762,700128,9524,759Nov 18 03:30 PM
Shaw Alan H.EVP & Chief Marketing OfficerNov 16Sale103.171,654170,6402,622Nov 18 03:30 PM
Squires James AChairman, President and CEONov 11Option Exercise42.764,676199,93749,643Nov 14 10:41 AM
STEWART MARTA REVP-Finance and CFONov 11Sale100.901,970198,7739,774Nov 14 10:15 AM
STEWART MARTA REVP-Finance and CFONov 10Sale100.082,017201,86111,744Nov 14 10:15 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 09Option Exercise38.7114,417558,010136,234Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 09Option Exercise38.714,417170,9604,417Nov 10 09:58 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 09Sale99.004,417437,2980Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 09Sale97.0014,4171,398,449121,817Nov 10 09:45 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 08Option Exercise38.7110,000387,050142,647Nov 10 09:45 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 08Option Exercise50.744,530229,8524,530Nov 10 09:58 AM
Earhart Cynthia CExec. VP - Admin. and CIONov 08Sale96.184,530435,6730Nov 10 09:58 AM
HIXON JAMES AExec. VP-Law & Corp. RelationsNov 08Sale95.4820,8301,988,850121,817Nov 10 09:45 AM
STEWART MARTA REVP-Finance and CFONov 07Sale94.102,023190,3647,824Nov 08 03:43 PM
Hurlbut Thomas EVice President and ControllerNov 07Sale94.461,00094,4617,560Nov 08 03:44 PM
Hurlbut Thomas EVice President and ControllerOct 27Sale91.212,170197,9208,560Oct 28 04:43 PM
AET Aetna Inc. daily Stock Chart
AET [NYSE]
Aetna Inc.
IndexS&P 500 P/E33.03 EPS (ttm)4.59 Insider Own0.20% Shs Outstand335.20M Perf Week-4.29%
Market Cap50.76B Forward P/E14.91 EPS next Y10.16 Insider Trans-19.74% Shs Float330.75M Perf Month-6.91%
Income1.57B PEG3.50 EPS next Q2.07 Inst Own92.40% Short Float0.73% Perf Quarter-1.22%
Sales62.20B P/S0.82 EPS this Y-5.50% Inst Trans-0.01% Short Ratio1.34 Perf Half Y17.82%
Book/sh46.33 P/B3.27 EPS next Y6.79% ROA2.50% Target Price166.13 Perf Year38.12%
Cash/sh10.66 P/C14.20 EPS next 5Y9.44% ROE9.50% 52W Range104.59 - 164.52 Perf YTD22.12%
Dividend2.00 P/FCF35.01 EPS past 5Y4.20% ROI7.40% 52W High-5.57% Beta0.58
Dividend %1.32% Quick Ratio- Sales past 5Y13.30% Gross Margin- 52W Low48.54% ATR2.67
Employees49500 Current Ratio- Sales Q/Q-2.70% Oper. Margin5.10% RSI (14)46.52 Volatility1.86% 1.79%
OptionableYes Debt/Eq0.60 EPS Q/Q61.00% Profit Margin2.50% Rel Volume0.79 Prev Close151.44
ShortableYes LT Debt/Eq0.47 EarningsOct 31 BMO Payout27.00% Avg Volume1.80M Price155.36
Recom2.20 SMA20-0.82% SMA50-1.23% SMA2009.43% Volume1,132,990 Change2.59%
Aug-04-17Reiterated RBC Capital Mkts Outperform $162 → $171
Jun-28-17Initiated Citigroup Buy $180
Jun-09-17Reiterated RBC Capital Mkts Outperform $147 → $162
Jun-07-17Initiated Morgan Stanley Overweight
May-16-17Reiterated Stifel Buy $150 → $158
Apr-05-17Initiated Deutsche Bank Hold $135
Jan-24-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-04-17Initiated Piper Jaffray Neutral
Nov-14-16Downgrade Bernstein Outperform → Mkt Perform
Nov-11-16Upgrade Credit Suisse Neutral → Outperform
Jun-16-16Initiated Bernstein Outperform
Apr-29-16Reiterated RBC Capital Mkts Outperform $140 → $144
Feb-02-16Reiterated Wedbush Neutral $130 → $120
Feb-02-16Reiterated RBC Capital Mkts Outperform $142 → $140
Jan-08-16Downgrade Jefferies Buy → Hold
Dec-16-15Initiated Credit Suisse Neutral
Sep-18-15Upgrade Cantor Fitzgerald Hold → Buy
Sep-16-15Initiated JP Morgan Overweight
Sep-08-15Upgrade RBC Capital Mkts Sector Perform → Outperform $159 → $162
Jul-30-15Upgrade BofA/Merrill Neutral → Buy $132
Oct-17-17 10:38AM  A Look at Aetnas Dividend Yield Path Market Realist
Oct-14-17 07:49PM  Sorry Everybody, But Trump Hasn't Instigated The Obamacare Apocalypse Forbes
Oct-13-17 11:21PM  [$$] Its Open-Enrollment Time: What Health Plan Should I Pick? The Wall Street Journal
11:43AM  How The CEOs of Americas Top Companies Are Stepping Up In Big Ways Fortune
10:38AM  Trump to scrap a crucial part of Obamacare Yahoo Finance Video
09:29AM  The Zacks Analyst Blog Highlights: Royal Dutch Shell, Morgan Stanley, Aetna, Johnson Controls International and LyondellBasell Industries Zacks
09:00AM  Aetna Once Again Outperforms Industry Average in Latest Medicare Star Ratings Business Wire
Oct-12-17 06:43PM  Top Analyst Reports for Royal Dutch Shell, Morgan Stanley & Aetna Zacks
01:18PM  Trump to unwind Obamacare with new exec. order Yahoo Finance Video
Oct-11-17 05:12PM  Potential Takeover Candidate Molina Names New CEO TheStreet.com
08:22AM  Aetna, Inc. breached its 50 day moving average in a Bearish Manner : AET-US : October 11, 2017 Capital Cube
Oct-10-17 07:30AM  Dividend Coverage: This Health Care Benefit Company has an Annualized Payout of $2.00; Will Trade Ex-Dividend on October 11, 2017 ACCESSWIRE
Oct-09-17 08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
12:34AM  [$$] Boutique Office Buildings Attract Big-Name Tenants The Wall Street Journal
Oct-08-17 09:38PM  [$$] Boutique Office Buildings Attract Big-Name Tenants The Wall Street Journal
Oct-07-17 08:39AM  Why Aetna Inc (AET) Delivered An Inferior ROE Compared To The Industry Simply Wall St.
Oct-06-17 09:00AM  Why Companies Cant Just Write Checks to Do Good Fortune
Sep-29-17 01:30PM  Aetna Board of Directors Declares Quarterly Cash Dividend Business Wire
12:57PM  Does Aetna Incs (AET) PE Ratio Signal A Selling Opportunity? Simply Wall St.
03:00AM  Stocks Showing Rising Market Leadership: Aetna Earns 82 RS Rating Investor's Business Daily
Sep-28-17 09:35AM  Anthem Grows on Membership, Public Exchange Woes Hurt Zacks
Sep-27-17 09:00AM  Meals on Wheels America and Aetna Form Innovative Collaboration to Improve Senior Care Business Wire
08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-26-17 06:17PM  Demographic Changes, Diversification Aid Health Insurers Zacks
12:50PM  GOP health care bill is doomed as possible vote looms Yahoo Finance Video
08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-25-17 01:53PM  Trump: The largest tax cut in the history of our country Yahoo Finance Video
01:01PM  The CEOs of PepsiCo and Aetna on How Millennials Have Changed the Role of the CEO Fortune
Sep-24-17 07:07AM  7 Reasons Your Obamacare Premium Could Soar by a Double-Digit Percentage in 2018 Motley Fool
Sep-23-17 05:04PM  Trump pressures U.S. senators to back Republican healthcare bill Reuters
Sep-22-17 10:15AM  Anthem to Boost Medicare in Florida With HealthSun Buyout Zacks
09:30AM  Is Aetna Inc. (AET) a Great Stock for Value Investors? Zacks
Sep-21-17 05:30PM  What it takes to score the best job in America Yahoo Finance
08:57AM  5 Things Women Can Do to Become CEO of a Company Fortune
08:44AM  Versartis, Inc. (VSAR) in Focus: Stock Moves 11.5% Higher Zacks
08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-20-17 02:14PM  Short Sellers Take Aim at Vulnerable Health Carriers Investopedia
10:13AM  Envision Healthcare Makes Organizational Changes, Here's Why Zacks
09:56AM  Aetna, Inc. breached its 50 day moving average in a Bearish Manner : AET-US : September 20, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-19-17 07:59PM  As clock ticks, Republicans try to move ahead on Obamacare repeal Reuters
04:26PM  Healthcare Reform: Who Suffers? Barrons.com
03:03PM  Public Exchange Woes Hit Health Insurers: Stocks in Focus Zacks
01:30PM  New York City agency approves $9.4 million in tax breaks for Aetna Reuters
08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-18-17 10:43AM  5 Reasons Why You Should Buy Aetna's (AET) Stock Right Now Zacks
08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-17-17 01:18AM  Take Two: Inside Bill Cassidy's Plan To Replace Obamacare Forbes
Sep-15-17 10:53AM  4 HMO Stocks Standing Out in a Top-Ranked Industry Zacks
Sep-14-17 08:33AM  Why the Earnings Streak Will Continue for Aetna Inc. (AET) Zacks
08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-13-17 08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-12-17 04:25PM  Alexion Pharmaceuticals is moving its headquarters to Boston Associated Press
12:22PM  Alexion Pharmaceuticals is moving its headquarters to Boston Associated Press
10:46AM  6 GARP Stocks That Should Grace Your Portfolio Zacks
10:31AM  3 Big Stock Charts for Tuesday: Abbott Laboratories (ABT), Aetna Inc (AET) and Boston Scientific Corporation (BSX) InvestorPlace
08:37AM  Why Aetna Inc (AET) Could Be A Buy Simply Wall St.
08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-11-17 10:06AM  The Zacks Analyst Blog Highlights: Home Depot, Aetna, Dickinson, Kellogg and FirstEnergy Zacks
10:05AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
09:15AM  Universal Health (UHS) Grows on Buyouts, Expenses a Drag Zacks
Sep-08-17 05:18PM  Top Analyst Reports for Home Depot, Aetna & Becton, Dickinson Zacks
10:40AM  Aetna Offers Assistance to Members Affected by Hurricane Irma Business Wire
08:52AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-07-17 12:10PM  ETFs with exposure to Aetna, Inc. : September 7, 2017 Capital Cube
Sep-06-17 05:00PM  Aetna Executive to Present at CEO Investor Forum 2.0 Business Wire
10:05AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
08:38AM  Aetna, Inc. :AET-US: Earnings Analysis: Q2, 2017 By the Numbers : September 6, 2017 Capital Cube
Sep-05-17 08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Sep-01-17 02:57PM  Anthem cuts back Obamacare coverage in Missouri to 68 counties Reuters
Aug-31-17 11:07AM  Zacks.com featured highlights include Lantheus Holdings, Jazz Pharmaceuticals, Gray Television, Aetna and Uniti Group Zacks
08:24AM  Molina Healthcare's Top Line Grows on Membership, Debts Hurt Zacks
Aug-30-17 12:21PM  These companies are donating $1 million or more to Harvey relief efforts CNBC
10:36AM  Humana (HUM) Hits 52-Week High on Solid Q2, Raised Outlook Zacks
07:31AM  5 Excellent Value Stocks Based on Low PEG Ratio Zacks
Aug-29-17 05:00PM  Aetna Executive to Present at Morgan Stanley Global Healthcare Conference Business Wire
04:20PM  Aetna scoops up rising star from Wal-Mart's health group to lead Apple Watch partnership CNBC
07:59AM  WellCare Health Partners Mission Health to Improve Offerings Zacks
07:53AM  Centene (CNC) Poised to Grow on Buyouts, High Debt Bothers Zacks
Aug-28-17 01:56PM  Expect a few weeks of pain at the pump and in the portfolio: NYSE trader Yahoo Finance Video
01:10PM  Hurricane Harvey's $30B in damages to oil, retail and insurers Yahoo Finance Video
12:47PM  Texas crippled by catastrophic flood Yahoo Finance Video
Aug-27-17 05:57PM  Aetna Offers Assistance to Members Affected by Hurricane Harvey in Texas and Louisiana Business Wire
Aug-25-17 11:51AM  Aetna Letters Publicly Revealed Patients' HIV Status Consumer Reports
Aug-24-17 03:23PM  Aetna Accidentally Reveals HIV Status of Clients in Mailing to 12,000 Bloomberg
11:43AM  Lawyers: Aetna envelope window reveals patients' HIV status Associated Press
10:17AM  Is Fitbit Inc (FIT) Stock a Buy on Recent Apple Inc. (AAPL) Watch News? InvestorPlace
Aug-23-17 05:10PM  Aetna, Inc. Value Analysis (NYSE:AET) : August 23, 2017 Capital Cube
Aug-22-17 03:06PM  Fitbit Buyout Speculation Is Pretty Ridiculous Motley Fool
02:07PM  Aetna, Inc. : AET-US: Dividend Analysis : July 13th, 2017 (record date) : By the numbers : August 22, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Aetna Inc. Markit
Aug-21-17 10:15AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aetna Inc. (AET) PR Newswire
08:31AM  Why Aetna (AET) Could Be a Top Value Stock Pick Zacks
07:30AM  Earnings Review and Free Research Report: Aetnas Adjusted EPS Soared 55% ACCESSWIRE
Aug-20-17 06:20PM  Healthcare Management Stocks Look Too Pricey for Activists TheStreet.com
Aug-19-17 10:31AM  Free Apple Watches? Aetna's Considering It Motley Fool
Aug-17-17 03:12PM  Apple and Aetna met last week to talk about the Apple Watchhere's what they discussed CNBC
09:46AM  Cigna Hits 52-Week High On Strong Q2 Results, Upbeat View Zacks
08:49AM  Apple to Solidify Wearable Biz With Aetna Deal; Vapes Lift Tobacco Abroad -ICYMI TheStreet.com
Aug-16-17 05:19PM  Aetna CEO says 'I am ashamed' of President Trump's 'behavior and comments' CNBC
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products, including pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. has a collaborative agreement with Community Care Physician Network, LLC to deliver healthcare services in North Carolina. The company was founded in 1853 and is based in Hartford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SOISTMAN FRANCIS S JRExec. VP, Government ServicesSep 18Option Exercise101.5066,7076,770,79190,161Sep 20 04:39 PM
Lynch Karen SPresidentSep 18Sale161.9115,2712,472,52664,261Sep 20 04:40 PM
McCarthy Margaret MEVP, Operations & TechnologySep 15Sale162.8510,2881,675,42333,563Sep 19 04:15 PM
Lynch Karen SPresidentSep 12Option Exercise72.2653,7733,885,637118,034Sep 14 04:45 PM
McCarthy Margaret MEVP, Operations & TechnologySep 08Option Exercise72.2635,0002,529,10068,563Sep 12 04:42 PM
Lynch Karen SPresidentJun 07Sale149.727,8251,171,55064,261Jun 09 04:03 PM
McCarthy Margaret MEVP, Operations & TechnologyJun 07Sale149.2327,0284,033,33433,563Jun 09 04:02 PM
Lynch Karen SPresidentJun 02Option Exercise72.2630,0002,167,80095,382Jun 06 04:26 PM
Bertolini Mark TChairman and CEOMay 17Sale140.79103,54714,578,523351,246May 18 04:49 PM
Bertolini Mark TChairman and CEOMay 16Option Exercise48.65308,64215,015,433659,888May 18 04:49 PM
Coye Molly JoelDirectorMay 09Sale142.18880125,1186,637May 11 05:02 PM
GUERTIN SHAWN MExec. Vice President, CFOMar 23Sale128.418,4341,083,00944,880Mar 23 04:25 PM
GUERTIN SHAWN MExec. Vice President, CFOMar 22Option Exercise101.5379,1198,033,139123,999Mar 23 04:25 PM
GUERTIN SHAWN MExec. Vice President, CFOMar 22Sale128.619,4971,221,37944,880Mar 23 04:25 PM
GUERTIN SHAWN MExec. Vice President, CFOMar 21Option Exercise72.2642,2503,052,98587,130Mar 23 04:25 PM
GUERTIN SHAWN MExec. Vice President, CFOMar 21Sale130.6211,6711,524,51444,880Mar 23 04:25 PM
SOISTMAN FRANCIS S JRExec. VP, Government ServicesMar 08Sale131.986,607872,02023,454Mar 10 04:09 PM
SOISTMAN FRANCIS S JRExec. VP, Government ServicesMar 06Option Exercise72.6054,8333,980,87671,680Mar 07 05:47 PM
McCarthy Margaret MEVP, Operations & TechnologyFeb 22Sale128.877,9301,021,91148,310Feb 24 04:31 PM
Bertolini Mark TChairman and CEOFeb 03Option Exercise42.57148,1386,306,235391,808Feb 07 04:27 PM
Coye Molly JoelDirectorNov 30Sale131.171,145150,1877,517Dec 02 05:11 PM
Lynch Karen SPresidentNov 11Sale119.5545,0005,379,92651,254Nov 15 04:06 PM
Coye Molly JoelDirectorNov 09Sale116.96862100,8208,662Nov 14 05:33 PM
SOISTMAN FRANCIS S JRExec. VP, Government ServicesNov 07Sale109.789,1501,004,47812,367Nov 09 04:14 PM
SRE Sempra Energy daily Stock Chart
SRE [NYSE]
Sempra Energy
IndexS&P 500 P/E16.91 EPS (ttm)6.77 Insider Own0.10% Shs Outstand253.46M Perf Week1.62%
Market Cap29.01B Forward P/E20.60 EPS next Y5.56 Insider Trans-8.32% Shs Float250.77M Perf Month-4.05%
Income1.70B PEG1.82 EPS next Q1.04 Inst Own85.60% Short Float1.96% Perf Quarter2.01%
Sales10.99B P/S2.64 EPS this Y1.50% Inst Trans0.01% Short Ratio4.85 Perf Half Y1.74%
Book/sh53.02 P/B2.16 EPS next Y6.21% ROA3.60% Target Price123.18 Perf Year10.05%
Cash/sh0.88 P/C130.09 EPS next 5Y9.30% ROE13.10% 52W Range92.95 - 120.17 Perf YTD13.73%
Dividend3.29 P/FCF- EPS past 5Y-0.20% ROI3.90% 52W High-4.91% Beta0.63
Dividend %2.87% Quick Ratio0.40 Sales past 5Y0.30% Gross Margin99.60% 52W Low22.94% ATR1.51
Employees16575 Current Ratio0.50 Sales Q/Q18.10% Oper. Margin20.70% RSI (14)45.59 Volatility1.38% 1.21%
OptionableYes Debt/Eq1.36 EPS Q/Q1518.80% Profit Margin15.50% Rel Volume0.67 Prev Close114.46
ShortableYes LT Debt/Eq1.13 EarningsNov 01 BMO Payout45.50% Avg Volume1.01M Price114.27
Recom2.00 SMA20-0.44% SMA50-2.02% SMA2002.27% Volume541,178 Change-0.17%
Oct-11-17Upgrade Goldman Neutral → Buy
Jun-08-17Downgrade Barclays Overweight → Equal Weight $121
Feb-29-16Reiterated Barclays Overweight $111 → $110
Jan-25-16Reiterated RBC Capital Mkts Outperform $119 → $116
May-06-15Reiterated Barclays Overweight $117 → $120
Sep-22-14Reiterated RBC Capital Mkts Outperform $106 → $115
Aug-14-14Reiterated UBS Buy $106 → $111
Apr-14-14Initiated UBS Buy $106
Apr-02-14Reiterated RBC Capital Mkts Outperform $102 → $104
Jan-06-14Reiterated Barclays Overweight $101 → $97
May-28-13Upgrade Barclays Equal Weight → Overweight $85 → $90
Apr-24-13Reiterated Barclays Equal Weight $77 → $85
Apr-23-13Downgrade ISI Group Buy → Neutral
Feb-27-13Reiterated Barclays Equal Weight $70 → $77
Jan-07-13Upgrade ISI Group Neutral → Buy
Jul-23-12Downgrade Argus Buy → Hold
Apr-03-12Reiterated Barclays Equal Weight $60 → $63
Nov-07-11Reiterated RBC Capital Mkts Sector Perform $54 → $57
Jun-24-11Initiated RBC Capital Mkts Sector Perform $55
Apr-08-11Reiterated Barclays Capital Equal Weight $54 → $57
Oct-17-17 09:10AM  S&P 500 Utilities: Recent Ratings Changes Market Realist
Oct-16-17 09:00AM  Sempra Energy To Report Third-Quarter 2017 Earnings Oct. 30 PR Newswire
07:41AM  Reading PG&Es Analysts Price Targets: Is Wildfire an Opportunity? Market Realist
Oct-13-17 10:12AM  [$$] Energy Future, Elliott Challenge Vistra on Taxes The Wall Street Journal
Oct-11-17 02:56PM  SoCalGas and U.S. Department of Energy's National Renewable Energy Laboratory Install Nation's First Biomethanation Reactor System for Power-to-Gas Testing PR Newswire
Oct-10-17 10:13AM  Sempra Energy : SRE-US: Dividend Analysis : September 22nd, 2017 (record date) : By the numbers : October 10, 2017 Capital Cube
07:20AM  Featured Company News - Sempra's IEnova Acquires Pemex's Participation in Los Ramones II Norte Pipeline ACCESSWIRE
Oct-09-17 08:38AM  Sempra (SRE) Unit Buys Mexico Pipeline Interest for $520M Zacks
07:38AM  How Analysts View PG&Es Recent Stock Changes Market Realist
06:11AM  Nuevo Leon, State of -- Moody's takes rating action on Nuevo Leon's debt ratings of four enhanced loans Moody's
Oct-06-17 07:00PM  Sempra Energy's IEnova Unit Acquires Pemex's Participation In The Los Ramones II Norte Pipeline PR Newswire
02:44PM  Nuevo Leon, State of -- Moody's takes rating action on Nuevo Leon's debt ratings of four enhanced loans Moody's
Oct-05-17 06:46PM  [$$] Sempra, Oncor Seek Deal Approval from Texas PUC The Wall Street Journal
10:15AM  Sempra Gets Less Messy With Texas Bloomberg
09:34AM  Industry Leaders to Share Expertise on Renewable Natural Gas Business Development PR Newswire
Oct-04-17 07:19PM  [$$] Sempra Revises Oncor Takeover Financing The Wall Street Journal
04:46PM  Sempra Falls on Plan to Issue More Equity to Get Oncor Approved Bloomberg
04:10PM  Oncor And Sempra Energy To File For Texas Regulatory Approval PR Newswire
Oct-03-17 07:18PM  Sempra Energy To Hold Oct. 4 Conference Call For Oncor Transaction Update PR Newswire
Sep-29-17 03:46PM  Thousands More Mobile Home Park Residents to Benefit from New Natural Gas Infrastructure and Technology PR Newswire
Sep-27-17 05:01PM  [$$] Temporary Truce in Fighting Over NextEra Breakup Fee The Wall Street Journal
10:39AM  ETFs with exposure to Sempra Energy : September 27, 2017 Capital Cube
08:06AM  See what the IHS Markit Score report has to say about Sempra Energy. Markit
Sep-25-17 08:05AM  See what the IHS Markit Score report has to say about Sempra Energy. Markit
Sep-22-17 08:19AM  Sempra Energy breached its 50 day moving average in a Bearish Manner : SRE-US : September 22, 2017 Capital Cube
08:05AM  See what the IHS Markit Score report has to say about Sempra Energy. Markit
Sep-21-17 01:35PM  Debra L. Reed Ranked Among Fortune's 'Most Powerful Women in Business' For 2017 PR Newswire
08:06AM  See what the IHS Markit Score report has to say about Sempra Energy. Markit
Sep-20-17 11:09AM  What Led to Sempra Energys Sharp Fall in Dividend Yield? Market Realist
Sep-19-17 02:20PM  [$$] Judge to Reconsider NextEra-Oncor Breakup Fee The Wall Street Journal
Sep-18-17 03:27PM  SoCalGas Announces Methane Capture Initiative Has Collected and Reused More than 1 Million Cubic Feet of Natural Gas PR Newswire
07:39AM  Sempra Energys Earnings and Dividend Growth Outlook Market Realist
Sep-15-17 01:36PM  A Look at Sempra Energys Dividend Statistics Market Realist
12:06PM  Sempra Energy Aims for Above-Average Dividend Growth Market Realist
10:13AM  Analyzing Sempra Energys Dividends ahead of Ex-Dividend Date Market Realist
Sep-13-17 05:00PM  Sempra Energy Named To Dow Jones Sustainability North America Index For 7th Year PR Newswire
Sep-12-17 06:22PM  Home Capital investors spurn Buffett's plan to boost stake Reuters
08:23AM  Should You Hold Sempra Energy Stock in Your Portfolio Now? Zacks
Sep-08-17 01:05PM  Sempra Energy Declares Common Dividend PR Newswire
Sep-07-17 09:07AM  PPL, XEL, and SCG: Any Steam Left in These Utilities? Market Realist
Sep-06-17 04:37PM  Morning Sector Snapshot: Oil Majors, Department Stores Rise Barrons.com
04:12PM  Court approves Sempras bid for Oncor ahead of Buffett American City Business Journals
03:14PM  U.S. Bankruptcy Court Approves Sempra Energy's Merger Agreement With Energy Future PR Newswire
10:37AM  More mega deals ahead? CNBC Videos
08:05AM  See what the IHS Markit Score report has to say about Sempra Energy. Markit
Sep-01-17 02:33AM  Sempra LNG & Midstream Media Statement In Response To Hurricane Harvey PR Newswire
Aug-31-17 09:07PM  ETFs with exposure to Sempra Energy : September 1, 2017 Capital Cube
08:06AM  See what the IHS Markit Score report has to say about Sempra Energy. Markit
07:50AM  Corporate News Blog - FuelCell Energy to Host Fuel Cell Project with NRG Energy Center ACCESSWIRE
Aug-29-17 08:06AM  See what the IHS Markit Score report has to say about Sempra Energy. Markit
Aug-28-17 11:27AM  Sempra Energy :SRE-US: Earnings Analysis: Q2, 2017 By the Numbers : August 28, 2017 Capital Cube
08:06AM  See what the IHS Markit Score report has to say about Sempra Energy. Markit
07:36AM  SRE, PCG, and EIX: Analysts Views, Outlook, and Price Targets Market Realist
Aug-26-17 03:00PM  Two U.S. Utility Giants Just Got Even Larger Oilprice.com
Aug-25-17 12:02PM  Sempra Does a Lot for a Little From Oncor Bloomberg
10:37AM  Institutional Investment in California Utilities Market Realist
09:07AM  Why SRE, PCG, and EIX Yield Lower Market Realist
08:16AM  Utilities ETFs in Focus on Oncor Bidding War (Revised) Zacks
07:37AM  Which SPX Utility Has the Most Alarming Leverage? Market Realist
Aug-24-17 04:47PM  [$$] Texas Regulators Wary of Latest Deal for Utility Business Oncor The Wall Street Journal
02:36PM  SPX Utilities Look Fairly Valued despite Their Epic Rally Market Realist
01:06PM  What SRE, PCG, and EIXs Chart Indicators Mean Market Realist
11:23AM  SRE, PCG, and EIX: Analyzing Their Total Returns Market Realist
11:22AM  How Are California Utilities Positioned for the Future? Market Realist
08:35AM  UPDATE: Berkshire Hathaway: Even When It Loses It Wins? Not Quite. Barrons.com
Aug-23-17 06:33PM  [$$] Buffett/Oncor: eclipsed Financial Times
11:00AM  Sempra Energy To Hold Conference Call Aug. 25 On Oncor Transaction PR Newswire
07:38AM  Sempra Energys Price Targets and Analysts Recommendations Market Realist
Aug-22-17 02:48PM  SoCalGas Streamlines Processes to Support Renewable Gas Projects PR Newswire
02:21PM  Why billionaire investors like Warren Buffett are chasing... CNBC Videos
01:35PM  Sempra Energys Current Valuation and Dividend Profile Market Realist
12:05PM  Sempra Energys Debt Profile before the Oncor Deal Market Realist
10:28AM  Where Could Sempra Energy Stock Go from Here? Market Realist
10:28AM  Sempra Energy Beat Berkshire Hathaway in a Bid to Buy Oncor Market Realist
10:19AM  Utilities ETFs in Focus on Oncor Bidding War Zacks
10:11AM  Company News For August 22, 2017 Zacks
08:05AM  Sempra Energy to Acquire Oncor for $18.8B, Beats Buffet Zacks
Aug-21-17 11:22PM  Asian stocks mixed after Wall Street gains Associated Press
05:48PM  Sempra Energy buys Oncor in last-minute deal Investing.com
05:25PM  Buffett encounters rare miss as Sempra Energy strikes deal to buy Oncor MarketWatch
05:14PM  [$$] Texas Regulators are First Test for Sempra's Oncor Deal The Wall Street Journal
05:10PM  Business Highlights Associated Press
03:54PM  Sempra Energy to buy Oncor for $9.45 billion in blow to Berkshire Reuters
03:43PM  Sempra Energy to buy Oncor for $9.45B CNBC Videos
03:25PM  Sempra Energy exec on Oncor bid: Fourth times a charm American City Business Journals
02:54PM  Oncor Is Buffett's Latest Dealmaking Flop Bloomberg
01:29PM  Big movers in the trader blitz CNBC Videos
12:55PM  [$$] Sempra Energy Reaches Deal to Buy Oncor After Outbidding Berkshire The Wall Street Journal
12:49PM  Sempra to buy Oncor for $9.5 bln Reuters Videos
12:06PM  US stock indexes hold steady after back-to-back down weeks Associated Press
12:04PM  Sempra Energy bids $9.45B for Oncor, topping Buffett offer Associated Press
10:13AM  Sempra Dares Buffett to Be Disciplined Bloomberg
10:00AM  Oncor No Great Loss for Buffett Morningstar
09:54AM  Sempra Reaches $9.45B Deal For Oncor Barrons.com
09:41AM  Stocks to Watch: Sempra Energy, Fiat Chrysler, Herbalife, ADP, B&G Foods, Nike The Wall Street Journal
08:30AM  3 Stocks to Watch on Monday: Lions Gate Entertainment Corp. (USA) (LGF), Microsoft Corporation (MSFT) and Sempra Energy (SRE) InvestorPlace
08:21AM  Bankrupt utility company abandons $9 billion Warren Buffe... CNBC Videos
08:05AM  See what the IHS Markit Score report has to say about Sempra Energy. Markit
07:57AM  Sempra Energy bids $9.45B for Oncor, topping Buffett offer Associated Press
07:48AM  Early movers: SRE, ADP, FCAU, TCS, NVS, GS, EA & more CNBC
Sempra Energy, together with its subsidiaries, engages in energy business worldwide. The company's San Diego Gas & Electric Company segment transmits and distributes electricity and/or natural gas. As of December 31, 2016, this segment had approximately 1.4 million electric meters and 878,000 natural gas meters. Its Southern California Gas Company segment purchases, transports, sells, distributes, and stores natural gas. As of December 31, 2015, this segment had approximately 5.9 million customer meters. The company's Sempra South American Utilities segment provides electricity distribution services through 10,118 miles of distribution lines, 352 miles of transmission lines, and 48 substations located in the region of Valparaiso in central Chile, as well as through 13,763 miles of distribution lines, 194 miles of transmission lines, and 39 substations located in the Cusco region of Peru. Its Sempra Mexico segment owns, develops, and operates natural gas pipelines, ethane systems, and a liquid petroleum gas pipeline and associated storage terminals; electric generation facilities; natural gas distribution systems; and liquefied natural gas (LNG) regasification terminals. The company's Sempra Renewables segment is involved in the investment and development of wind and solar power generation facilities. Its Sempra LNG & Midstream segment invests in and develops LNG-related infrastructure in North America; develops and operates natural gas storage facilities in Alabama and Mississippi; and owns a liquefaction project in Louisiana. The company primarily serves residential, commercial, and industrial customers. Sempra Energy was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
REED DEBRA LChairman, CEO and PresidentMay 23Sale113.4323,0002,608,982104,645May 24 05:23 PM
OUCHI WILLIAM GDirectorMar 06Option Exercise46.025,000230,10021,247Mar 06 03:34 PM
OUCHI WILLIAM GDirectorMar 06Sale108.925,000544,60016,247Mar 06 03:34 PM
RUTLEDGE WILLIAM PDirectorMar 02Option Exercise52.5910,000525,85015,846Mar 02 05:45 PM
OUCHI WILLIAM GDirectorMar 02Sale109.8760065,92216,247Mar 03 02:42 PM
RUTLEDGE WILLIAM PDirectorMar 02Sale109.6915,2621,674,089584Mar 02 05:45 PM
DAVIS STEVEN DCorp. Group PresidentFeb 13Sale105.002,233234,46520,567Feb 13 05:18 PM
HOUSEHOLDER JOSEPH ACorp. Group PresidentJan 24Sale102.106,472660,79147,425Jan 24 08:43 PM
REED DEBRA LChairman and CEOJan 23Sale102.3417,3001,770,482127,645Jan 23 07:20 PM
ROWLAND G JOYCESenior VPJan 19Sale102.592,862293,6131Jan 19 02:00 PM
Martin Jeffrey WExecutive VP and CFOJan 10Sale100.954,266430,6730Jan 10 01:57 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFODec 12Option Exercise61.4112,000736,92059,425Dec 13 04:42 PM
SNELL MARK APresidentDec 12Sale103.0635,0003,607,10037,914Dec 13 04:41 PM
HOUSEHOLDER JOSEPH AExecutive VP and CFODec 12Sale102.6912,0001,232,28047,425Dec 13 04:42 PM
ROWLAND G JOYCESenior VPDec 08Sale99.1212512,3901Dec 09 04:11 PM
BOECKMANN ALAN LDirectorNov 29Buy101.526,000609,1166,000Nov 29 06:26 PM
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E57.46 EPS (ttm)3.50 Insider Own0.10% Shs Outstand224.63M Perf Week1.87%
Market Cap45.11B Forward P/E19.31 EPS next Y10.40 Insider Trans-32.50% Shs Float224.63M Perf Month2.81%
Income759.00M PEG5.33 EPS next Q2.37 Inst Own90.40% Short Float5.91% Perf Quarter-0.09%
Sales12.16B P/S3.71 EPS this Y34.00% Inst Trans0.11% Short Ratio11.71 Perf Half Y9.51%
Book/sh57.00 P/B3.52 EPS next Y9.97% ROA2.70% Target Price219.00 Perf Year16.80%
Cash/sh61.74 P/C3.25 EPS next 5Y10.78% ROE8.50% 52W Range161.29 - 206.63 Perf YTD21.30%
Dividend2.92 P/FCF43.50 EPS past 5Y-3.30% ROI6.60% 52W High-1.77% Beta1.04
Dividend %1.45% Quick Ratio5.00 Sales past 5Y10.50% Gross Margin48.90% 52W Low25.84% ATR2.43
Employees50900 Current Ratio5.60 Sales Q/Q-5.10% Oper. Margin9.30% RSI (14)65.09 Volatility1.08% 1.14%
OptionableYes Debt/Eq1.51 EPS Q/Q-141.60% Profit Margin6.20% Rel Volume0.45 Prev Close200.82
ShortableYes LT Debt/Eq1.47 EarningsNov 02 BMO Payout79.50% Avg Volume1.13M Price202.97
Recom1.90 SMA203.69% SMA502.62% SMA2007.59% Volume403,161 Change1.07%
Sep-22-17Initiated Wells Fargo Outperform $225
Jun-30-17Upgrade Raymond James Outperform → Strong Buy
Jan-05-17Downgrade Raymond James Strong Buy → Outperform
Jan-03-17Downgrade JP Morgan Overweight → Neutral
Sep-23-16Downgrade Citigroup Neutral → Sell
May-09-16Reiterated RBC Capital Mkts Sector Perform $153 → $169
Feb-11-16Upgrade Deutsche Bank Hold → Buy $155 → $163
Feb-04-16Reiterated RBC Capital Mkts Sector Perform $162 → $153
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-12-15Initiated Citigroup Neutral
Aug-19-15Reiterated Argus Buy $156 → $167
Aug-10-15Reiterated Deutsche Bank Hold $147 → $155
Aug-07-15Reiterated RBC Capital Mkts Sector Perform $150 → $162
Jul-02-15Resumed Barclays Equal Weight $158
Jun-29-15Upgrade UBS Neutral → Buy $159 → $167
Mar-24-15Reiterated Canaccord Genuity Hold $125 → $149
Mar-10-15Initiated UBS Neutral $159
Feb-11-15Reiterated Argus Buy $140 → $156
Feb-06-15Reiterated RBC Capital Mkts Outperform $145 → $150
Oct-08-14Reiterated RBC Capital Mkts Sector Perform $116 → $132
Oct-09-17 08:15AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bullish Manner : BDX-US : October 9, 2017 Capital Cube
08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Oct-06-17 11:43AM  Behind BDs Latest Analyst Recommendations Market Realist
Oct-05-17 04:30PM  BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call PR Newswire
Oct-03-17 10:55AM  ETFs with exposure to Becton, Dickinson & Co. : October 3, 2017 Capital Cube
Oct-02-17 03:58PM  Becton, Dickinson's Charts Are Bullish TheStreet.com
Sep-29-17 10:42AM  Timothy M. Ring and David F. Melcher to Join BD Board of Directors PR Newswire
Sep-28-17 06:09AM  Becton Dickinson offers EU concessions over $24 bln Bard deal Reuters
Sep-27-17 09:55AM  Becton, Dickinson & Co. : BDX-US: Dividend Analysis : September 08th, 2017 (record date) : By the numbers : September 27, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
06:30AM  BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes PR Newswire
Sep-26-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
04:00AM  BD Expands Efforts to Combat Antimicrobial Resistance with New Diagnostic Test in Europe PR Newswire
Sep-25-17 08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Sep-22-17 11:03AM  ETFs with exposure to Becton, Dickinson & Co. : September 22, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Sep-21-17 12:09PM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: Q3, 2017 By the Numbers : September 21, 2017 Capital Cube
08:42AM  BD (BDX) Inks New Deal to Strengthen Foothold in STI Space Zacks
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Sep-20-17 10:16AM  Becton, Dickinson Ultra-Fine Needle to Improve Diabetic Care Zacks
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
04:00AM  BD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sexually-Transmitted Pathogens PR Newswire
Sep-19-17 06:59AM  BD Introduces New 6mm Pen Needle for Injection Pens PR Newswire
Sep-15-17 02:06PM  Whats BDs Recent Dividend Payment and Capital Allocation Strategy? Market Realist
12:35PM  BD Stock Fell 2.7% on September 13: Should Investors Worry? Market Realist
Sep-14-17 10:24AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : September 14, 2017 Capital Cube
Sep-12-17 09:42AM  Becton, Dickinson's (BCR) C.R. Bard Buyout Plans Bode Well Zacks
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
06:59AM  BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis PR Newswire
Sep-11-17 10:06AM  The Zacks Analyst Blog Highlights: Home Depot, Aetna, Dickinson, Kellogg and FirstEnergy Zacks
10:05AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Sep-08-17 05:18PM  Top Analyst Reports for Home Depot, Aetna & Becton, Dickinson Zacks
04:18PM  BD to Present at the Morgan Stanley Global Healthcare Conference 2017 PR Newswire
10:21AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Sep-06-17 07:40AM  Dividend Coverage: This Medical Tech Company has Raised Dividend for 45 Consecutive Years; Will Trade Ex-Dividend on September 07, 2017 ACCESSWIRE
03:00AM  Becton Dickinson Trying To Close In On Key Technical Benchmark Investor's Business Daily
Sep-01-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Aug-31-17 09:55AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : August 31, 2017 Capital Cube
Aug-30-17 10:35AM  Becton Dickinsons Recent Stock Performance Market Realist
09:06AM  Most Analysts Recommend a Buy for Becton Dickinson Market Realist
07:36AM  Becton Dickinson Raised Its 2017 Guidance, Expects Better Margins Market Realist
Aug-29-17 10:38AM  How Innovation Is Driving Becton Dickinsons Growth in 2017 Market Realist
09:07AM  Becton Dickinsons CareFusion Synergies and Integration Progress Market Realist
07:38AM  How Is Becton Dickinson Progressing with Emerging Market Growth? Market Realist
06:30AM  BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes PR Newswire
Aug-28-17 11:36AM  Becton Dickinsons Bard Acquisition: On Track, Gaining Momentum Market Realist
10:07AM  Headwind for Becton Dickinson: US Dispensing Business Market Realist
09:07AM  Analysts Post-1Q18 Recommendations for Medtronic Market Realist
08:22AM  Beckton Dickinson: Key Highlights of 3Q17 Results Market Realist
Aug-25-17 05:50PM  Medtronic Beats Earnings Estimates, Misses Revenue Estimates Market Realist
Aug-23-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Aug-22-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
07:40AM  Earnings Review and Free Research Report: Becton, Dickinson and Co.s Q3 Adjusted EPS Rose 4.7%; Beat Estimates ACCESSWIRE
Aug-21-17 05:48PM  Becton, Dickinson & Co. Value Analysis (NYSE:BDX) : August 21, 2017 Capital Cube
09:06AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : August 21, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Aug-18-17 12:09PM  FDA probes possible Becton Dickinson link to faulty lead tests (Aug. 17) Reuters
Aug-17-17 07:49PM  Becton Dickinson blood tubes not linked to inaccurate lead results -FDA Reuters
Aug-16-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
07:36AM  How Varian Is Harnessing Proton Therapy Market Opportunities Market Realist
Aug-14-17 10:38AM  A Look at Varian Medical Systems Long-Term Goals Market Realist
09:07AM  Varian Medical Systems: Better Aligned, More Focused Market Realist
Aug-12-17 09:31PM  Edited Transcript of BDX earnings conference call or presentation 3-Aug-17 12:00pm GMT Thomson Reuters StreetEvents
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Aug-11-17 08:00AM  IHS Markit Score Update: Rise in demand for ETFs holding Becton Dickinson and Co is a positive for its shares Markit
Aug-10-17 08:00AM  IHS Markit Score upgrades Becton Dickinson and Co to 71 out of 100, ranking positively in one IHS Markit category. Markit
Aug-09-17 10:04AM  Becton Dickinson and Co Faces a Rough Comparator Motley Fool
09:24AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : August 9, 2017 Capital Cube
08:00AM  IHS Markit Score downgrades Becton Dickinson and Co to 66 out of 100, ranking positively in only two out of four IHS Markit categories. Markit
07:27AM  C.R. Bard Shareholders Approve Merger With Becton, Dickinson Zacks
Aug-08-17 04:54PM  Bard Shareholders Approve Proposed Merger With Becton, Dickinson PR Newswire
Aug-04-17 02:10AM  Becton Dickinson reports 3Q loss Associated Press
Aug-03-17 08:11AM  Becton, Dickinson (BDX) Beats on Q3 Earnings, Guidance Solid Zacks
07:33AM  Becton, Dickinson (BDX) Tops Q3 Earnings, Misses On Revenues Zacks
06:00AM  BD Announces Results For 2017 Third Fiscal Quarter PR Newswire
Aug-01-17 09:08AM  Key Drivers behind BDXs Recent Stock Performance Market Realist
08:28AM  Becton, Dickinson (BDX) Q2 Earnings: What's in the Cards? Zacks
07:38AM  How BDX Returns Value to Its Shareholders Market Realist
06:55AM  BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes PR Newswire
06:27AM  Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways TheStreet.com
Jul-31-17 06:59PM  Cramer Remix: 3 red-hot stocks ready to roar higher CNBC
10:42AM  What Can We Expect from BDXs Fiscal 3Q17 Earnings? Market Realist
09:12AM  Could Becton Dickinson Exceed Analysts Estimates in Fiscal 3Q17? Market Realist
07:41AM  What Analysts Recommend for BDX before Its 3Q17 Results Market Realist
Jul-28-17 09:48AM  Align Technology (ALGN) Beats on Q2 Earnings and Revenues Zacks
Jul-27-17 12:02PM  Boston Scientific (BSX) Tops Q2 Earnings & Sales, View Up Zacks
Jul-26-17 12:19PM  Turn Pocket Change Into Millions With Seven Dividend-Paying Stocks Forbes
Jul-25-17 04:15PM  BD Board Declares Dividend PR Newswire
Jul-21-17 01:05PM  What Drove JNJs 2Q17 Results Market Realist
Jul-19-17 06:59AM  BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System PR Newswire
Jul-18-17 06:59AM  BD Transforms Microbiology Urine Testing PR Newswire
Jul-17-17 07:38AM  Abbott Laboratories Dividend Growth and Payout Potential in 2017 Market Realist
Jul-14-17 04:05PM  What to Expect from Abbott Laboratories 2Q17 Earnings Market Realist
Jul-11-17 07:37AM  Behind BDs Recent New Stock Price High Market Realist
Jul-10-17 10:38AM  How Attractive Is BDs Dividend? Market Realist
09:09AM  Inside the Latest BD Collaborations and Growth Accelerators Market Realist
09:03AM  Becton, Dickinson (BDX) Poised on C.R. Bard Acquisition Zacks
07:40AM  Which BD Product Launches Will Drive the Most Growth? Market Realist
Jul-07-17 06:04PM  Top Analyst Reports for Procter & Gamble, Verizon & Citigroup Zacks
Jul-06-17 08:00AM  BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call PR Newswire
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. It has a strategic collaboration with FlowJo, LLC. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COHEN GARY MExecutive Vice PresidentSep 11Option Exercise72.1224,0111,731,67395,781Sep 11 02:48 PM
COHEN GARY MExecutive Vice PresidentSep 11Sale203.7715,5123,160,88071,770Sep 11 02:48 PM
Sichak StephenExecutive Vice PresidentSep 08Option Exercise113.0427,0333,055,69219,047Sep 11 09:17 AM
Sichak StephenExecutive Vice PresidentSep 08Sale200.4611,7872,362,8227,953Sep 11 09:17 AM
Lim James CExecutive Vice PresidentSep 08Sale204.063,500714,21014,135Sep 11 09:10 AM
Tharby Linda MExecutive Vice PresidentAug 22Option Exercise72.127,333528,85618,670Aug 23 05:45 PM
COHEN GARY MExecutive Vice PresidentAug 22Option Exercise72.1223,5001,694,82095,270Aug 23 05:11 PM
Tharby Linda MExecutive Vice PresidentAug 22Sale200.484,695941,25411,337Aug 23 05:45 PM
COHEN GARY MExecutive Vice PresidentAug 22Sale200.4315,0443,015,26971,770Aug 23 05:11 PM
Shabshab NabilExecutive Vice PresidentAug 15Sale202.372,865579,7905,839Aug 16 10:12 AM
Shabshab NabilExecutive Vice PresidentAug 14Option Exercise140.2610,8431,520,88315,648Aug 16 10:12 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesAug 14Option Exercise76.1812,003914,38929,323Aug 14 04:52 PM
Shabshab NabilExecutive Vice PresidentAug 14Sale201.223,284660,8068,704Aug 16 10:12 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesAug 14Sale201.417,4631,503,12317,320Aug 14 04:52 PM
Strahlman Ellen RSenior Vice PresidentAug 10Option Exercise108.8920,6012,243,24326,638Aug 11 09:57 AM
Strahlman Ellen RSenior Vice PresidentAug 10Sale198.219,2831,839,9836,037Aug 11 09:57 AM
Polen Thomas E JrExecutive Vice PresidentAug 09Option Exercise98.9111,9711,184,06517,528Aug 10 10:08 AM
Polen Thomas E JrExecutive Vice PresidentAug 09Sale197.415,9711,178,7359,209Aug 10 10:08 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 25Option Exercise76.1848,7273,712,02370,821May 26 10:25 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 25Sale185.9828,7655,349,71522,094May 26 10:25 AM
SHERMAN JEFFREY SSr. VP and General CounselFeb 15Option Exercise72.1244,3643,199,53266,458Feb 16 08:57 AM
SHERMAN JEFFREY SSr. VP and General CounselFeb 15Sale180.0231,4645,664,24622,094Feb 16 08:57 AM
Conroy AlexandreExecutive Vice PresidentFeb 14Sale177.868,5001,511,81023,676Feb 15 11:31 AM
Gallagher John EVP, Corp Finance and TreasurerDec 15Sale168.821,793302,6942,796Dec 16 01:50 PM
Sichak StephenExecutive Vice PresidentDec 05Sale164.442,632432,8067,953Dec 06 01:48 PM
Sichak StephenExecutive Vice PresidentNov 04Option Exercise76.1818,2461,389,98026,892Nov 07 08:52 AM
Sichak StephenExecutive Vice PresidentNov 04Sale176.1010,3521,822,9878,646Nov 07 08:52 AM
HUM Humana Inc. daily Stock Chart
HUM [NYSE]
Humana Inc.
IndexS&P 500 P/E19.36 EPS (ttm)12.25 Insider Own0.10% Shs Outstand146.77M Perf Week-1.35%
Market Cap34.81B Forward P/E19.36 EPS next Y12.25 Insider Trans-57.53% Shs Float144.10M Perf Month-4.86%
Income1.81B PEG1.45 EPS next Q3.26 Inst Own97.80% Short Float2.30% Perf Quarter0.90%
Sales53.87B P/S0.65 EPS this Y-51.80% Inst Trans0.13% Short Ratio3.08 Perf Half Y12.03%
Book/sh75.75 P/B3.13 EPS next Y5.93% ROA6.10% Target Price263.29 Perf Year38.84%
Cash/sh55.45 P/C4.28 EPS next 5Y13.32% ROE16.80% 52W Range165.03 - 259.76 Perf YTD16.24%
Dividend1.60 P/FCF6.78 EPS past 5Y-13.60% ROI5.40% 52W High-7.18% Beta0.88
Dividend %0.67% Quick Ratio- Sales past 5Y8.10% Gross Margin- 52W Low46.11% ATR3.80
Employees51600 Current Ratio- Sales Q/Q-3.40% Oper. Margin6.20% RSI (14)46.10 Volatility1.32% 1.67%
OptionableYes Debt/Eq0.47 EPS Q/Q116.40% Profit Margin3.40% Rel Volume1.02 Prev Close237.17
ShortableYes LT Debt/Eq0.39 EarningsNov 08 BMO Payout10.30% Avg Volume1.08M Price241.12
Recom1.90 SMA20-0.11% SMA50-2.81% SMA2006.24% Volume873,827 Change1.67%
Oct-09-17Downgrade JP Morgan Overweight → Neutral $253
Jun-28-17Initiated Citigroup Buy $275
Jun-09-17Upgrade Argus Hold → Buy
Jun-07-17Initiated Morgan Stanley Overweight
Apr-21-17Downgrade Jefferies Buy → Hold
Apr-05-17Initiated Deutsche Bank Hold $216
Mar-30-17Resumed Oppenheimer Outperform
Jan-27-17Resumed BofA/Merrill Buy
Jan-24-17Downgrade Stifel Buy → Hold $214 → $210
Jan-04-17Initiated Piper Jaffray Overweight
Dec-07-16Downgrade Cantor Fitzgerald Buy → Hold
Nov-11-16Upgrade Credit Suisse Neutral → Outperform
Nov-10-16Upgrade JP Morgan Neutral → Overweight
Oct-13-16Reiterated RBC Capital Mkts Sector Perform $222 → $217
Jul-22-16Reiterated RBC Capital Mkts Outperform $220 → $224
Jul-22-16Reiterated FBR Capital Mkt Perform $220 → $170
Jul-18-16Upgrade Jefferies Hold → Buy $210
Jul-08-16Downgrade JP Morgan Overweight → Neutral $196 → $150
May-05-16Reiterated Stifel Buy $209 → $220
May-05-16Reiterated RBC Capital Mkts Sector Perform $209 → $220
Oct-17-17 01:30PM  Humana Expands Medicare Advantage Offerings in New Hampshire Business Wire
01:09PM  Humana appoints permanent leader for its foundation American City Business Journals
10:30AM  Humana Foundation Appoints Walter D. Woods as New Foundation Chief Executive Officer Business Wire
Oct-16-17 01:03PM  Trump's Decision To Cut Cost-Sharing Subsidies Hurt UnitedHealth And 4 Other Health Care Stocks Forbes
10:33AM  WellCare (WCG) Unit Receives Favorable Star Ratings From CMS Zacks
09:39AM  See what the IHS Markit Score report has to say about Humana Inc. Markit
Oct-14-17 07:49PM  Sorry Everybody, But Trump Hasn't Instigated The Obamacare Apocalypse Forbes
Oct-13-17 10:42AM  Buy These 4 Momentum Stocks for Exciting Returns Zacks
09:50AM  Humana, Inc. : HUM-US: Dividend Analysis : September 29th, 2017 (record date) : By the numbers : October 13, 2017 Capital Cube
07:45AM  Humana plans get better ratings, more money from federal government American City Business Journals
Oct-12-17 03:00PM  Humana Expands Affordable Hearing Aid Benefit in Medicare Advantage Plans Business Wire
11:50AM  The stock market rally isn't about tax cuts Yahoo Finance
09:04AM  Zacks.com featured highlights include article article Michael Kors Holdings, Humana, KEMET, Greenbrier Companies and Thor Industries Zacks
Oct-11-17 02:15PM  Medicare Star Quality Ratings Reflect Humanas Commitment to Quality Care for Its Members Business Wire
09:44AM  Molina Healthcare Appoints CEO: Will New Leadership Help? Zacks
09:40AM  Uptrending Stocks Near Technical Buy Points Investopedia
09:16AM  Believe in Driehaus Strategy and Buy These 5 Momentum Stocks Zacks
Oct-10-17 10:11AM  Humana Focuses on Enhanced Benefits and Value in 2018 Medicare Health Plans Business Wire
09:19AM  Zacks.com featured highlights: Humana, Alibaba Group Holding, Honeywell International, AGNC Investment and Wintrust Financial Zacks
Oct-09-17 09:30AM  5 Low Leverage Stocks That Can Be Part of Your Portfolio Zacks
08:59AM  Is It Time To Buy Humana Inc (HUM) Based Off Its PE Ratio? Simply Wall St.
08:37AM  WellCare Health Grows on Revenues, Debt Level Hurts Zacks
01:06AM  Why OPEC Says 'Extraordinary Steps' Are Needed Bloomberg Video
01:04AM  How Spain, Catalan Standoff Is Impacting the Markets Bloomberg Video
12:59AM  Catalan Leaders to Press Ahead With Independence Bloomberg Video
Oct-04-17 10:11AM  Humana Partners With Community Care, Improves Healthcare Zacks
09:00AM  Survey: Sense of Optimism Linked to the Perceived Mental and Physical Health of Seniors Business Wire
08:11AM  Humana, Inc. breached its 50 day moving average in a Bullish Manner : HUM-US : October 4, 2017 Capital Cube
Oct-03-17 12:00PM  Humana and Iora Health® Expand Footprint in Arizona to Provide Medicare Beneficiaries Access to a New Primary Care Practice Business Wire
11:18AM  ETFs with exposure to Humana, Inc. : October 3, 2017 Capital Cube
10:00AM  Community Care Physicians Signs Agreement with Humana Business Wire
Oct-02-17 04:30PM  Humana Inc. to Release Third Quarter 2017 Results on November 8, 2017 Business Wire
01:30PM  Humana, Texas A&M University Host Inaugural Health Care Analytics Case Competition for MS/MBA Students Business Wire
08:57AM  Humana, Inc. :HUM-US: Earnings Analysis: Q2, 2017 By the Numbers : October 2, 2017 Capital Cube
06:00AM  Cleveland Clinic and Humana Create Two New $0 Premium Medicare Advantage Health Plans Business Wire
Sep-28-17 11:30AM  Online Guide Designed to Provide Vital Resources to San Antonio Residents Affected by Diabetes Business Wire
09:35AM  Anthem Grows on Membership, Public Exchange Woes Hurt Zacks
09:00AM  Humana Named to Dow Jones Sustainability Indices for Eleventh Consecutive Year Business Wire
Sep-27-17 11:00AM  Humana Contracts with CleanSlate Centers to Provide Opioid Addiction Services Business Wire
09:15AM  Humana Earns Platinum Status with Best Employers for Healthy Lifestyles® Award Business Wire
Sep-26-17 06:17PM  Demographic Changes, Diversification Aid Health Insurers Zacks
03:05PM  Even with early-retirement program, Humana likely will have more layoffs American City Business Journals
Sep-25-17 03:24PM  Humana to offer early retirement for older employees American City Business Journals
09:15AM  Humana, Norton score really high in this ranking of the country's healthiest employers American City Business Journals
Sep-24-17 04:44PM  U.S. Senate opposition to Obamacare repeal bill grows Reuters
Sep-23-17 05:04PM  Trump pressures U.S. senators to back Republican healthcare bill Reuters
Sep-22-17 02:53PM  Healthcare stocks are rising after John McCain dealt a major blow to the Republican healthcare bill Business Insider
Sep-21-17 11:00AM  Humana Ranks No. 3 among Americas Healthiest 100 Workplaces Business Wire
08:00AM  See what the IHS Markit Score report has to say about Humana Inc. Markit
Sep-20-17 09:55AM  Humana, Inc. breached its 50 day moving average in a Bearish Manner : HUM-US : September 20, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Humana Inc. Markit
Sep-19-17 04:26PM  Healthcare Reform: Who Suffers? Barrons.com
03:03PM  Public Exchange Woes Hit Health Insurers: Stocks in Focus Zacks
10:15AM  Partners in Primary Care to Open Senior-focused Medical Center in Gastonia Business Wire
Sep-18-17 08:00AM  See what the IHS Markit Score report has to say about Humana Inc. Markit
Sep-15-17 08:00AM  See what the IHS Markit Score report has to say about Humana Inc. Markit
Sep-13-17 02:00PM  Partners in Primary Care to Open Four Senior-focused Medical Centers in Kansas and Missouri Business Wire
10:00AM  Joint Studies Suggest Relationship Between TV Age Bias and Health of Seniors Business Wire
Sep-12-17 04:07PM  3 Value Stocks in Health Insurance to Bet On Zacks
10:03AM  Humana Earns Gold Status in American Heart Associations Workplace Health Achievement Index Business Wire
09:03AM  Corporations, including Florida Blue, pledge millions in Hurricane Irma relief American City Business Journals
Sep-11-17 10:26AM  Humana Foundation Donates $1,000,000 to Support Hurricane Irma Relief Business Wire
08:00AM  See what the IHS Markit Score report has to say about Humana Inc. Markit
05:36AM  Humana (HUM) Up 6.4% Since Earnings Report: Can It Continue? Zacks
Sep-08-17 03:35PM  Humana Offers Support to Floridians Affected by Hurricane Irma Business Wire
07:00AM  New York City comptroller wields new clout in boardroom diversity drive Reuters
Sep-06-17 10:00AM  Humanas 2017 Corporate Social Responsibility Progress Report Highlights Companys Work to Inspire Health Business Wire
Aug-31-17 06:51PM  Cramer's lightning round: My playbook for Boeing CNBC
02:04PM  Humana cuts at-home care jobs in Louisville, nationally American City Business Journals
Aug-30-17 04:30PM  Humana Inc. to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Business Wire
10:36AM  Humana (HUM) Hits 52-Week High on Solid Q2, Raised Outlook Zacks
Aug-28-17 04:30PM  Humana Announces Completion of Accelerated Share Repurchase Program Business Wire
01:56PM  Expect a few weeks of pain at the pump and in the portfolio: NYSE trader Yahoo Finance Video
01:10PM  Hurricane Harvey's $30B in damages to oil, retail and insurers Yahoo Finance Video
12:47PM  Texas crippled by catastrophic flood Yahoo Finance Video
Aug-27-17 07:30PM  Humana Offers Support to Communities Impacted by Hurricane Harvey Business Wire
Aug-26-17 06:30PM  Humana Foundation Donates $250,000 to Support Hurricane Harvey Relief Business Wire
Aug-21-17 04:30PM  Humana Elects Frank Bisignano to Board of Directors Business Wire
10:15AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Humana Inc. (HUM) PR Newswire
07:50AM  Earnings Review and Free Research Report: Humana Reported Better Than Expected Earnings ACCESSWIRE
Aug-20-17 06:20PM  Healthcare Management Stocks Look Too Pricey for Activists TheStreet.com
09:12AM  3 Reasons Obamacare Premiums Are Set to Skyrocket in 2018 Motley Fool
Aug-18-17 03:30PM  Amgen in Collaboration With Humana for Patients' Benefit GuruFocus.com
10:57AM  [$$] Managed Care EPS Quality Improves Barrons.com
Aug-17-17 04:30PM  Humana Board Declares Payment of Quarterly Dividend to Stockholders Business Wire
04:00PM  Amgen And Humana Partner For Improved Health Outcomes And Efficiency PR Newswire
Aug-15-17 11:00AM  Summit Health Signs Medicare Network Agreement with Humana Business Wire
Aug-13-17 12:55AM  Edited Transcript of HUM earnings conference call or presentation 2-Aug-17 1:00pm GMT Thomson Reuters StreetEvents
Aug-12-17 08:00AM  See what the IHS Markit Score report has to say about Humana Inc. Markit
Aug-11-17 09:13AM  When Success Is About Doing Old Things in New Ways Fortune
06:25AM  Aetna's (AET) $1 Billion Notes Due 2047 Rated By A.M Best Zacks
Aug-09-17 08:00AM  See what the IHS Markit Score report has to say about Humana Inc. Markit
Aug-08-17 05:53PM  Humana, Inc. Value Analysis (NYSE:HUM) : August 8, 2017 Capital Cube
01:55PM  Medicare Advantage helps profits for Humana, other insurers American City Business Journals
01:46PM  Look Closer, Tenet Healthcare Is Making More Progress Than It Seems Benzinga
11:50AM  Tenet Dives After Worse Than Expected Quarter Leads to Lower 2017 Outlook TheStreet.com
06:50AM  Tenet Healthcare's (THC) Q2 Loss In Line with Estimates Zacks
Aug-07-17 10:03AM  The Zacks Analyst Blog Highlights: Apple, General Motors, Tesla, Northrop Grumman and Humana Zacks
Aug-04-17 04:52PM  Top Stock Reports for Apple, General Motors & Tesla Zacks
08:32AM  UPDATE 2-WellCare beats profit estimates, raises earnings forecast Reuters
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment offers Medicare benefits, as well as commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group segment offers commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; and administrative services only products, and health and wellness products to employer groups. It also provides military services, such as TRICARE South Region contract. The Healthcare Services segment offers pharmacy solutions, provider services, home based services, clinical programs, and predictive modeling and informatics services to its health plan members, as well as to third parties. The company also provides closed-block long-term care insurance policies. As of December 31, 2016, it had approximately 14.2 million members in medical benefit plans, as well as approximately 7.0 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bierbower Elizabeth DPresident, Group SegmentSep 01Sale259.009,7862,534,57418,042Sep 06 09:34 AM
Huval Timothy S.Senior VP & Chief HR OfficerSep 01Sale258.147,8032,014,3018,831Sep 05 12:40 PM
Wheatley Timothy AlanPresident, Retail SegmentAug 26Option Exercise0.001,60201,602Aug 29 09:37 AM
Fleming William KevinPresident, Hlthcare Svc SgmtAug 23Sale250.983,071770,7607,681Aug 25 01:32 PM
BROUSSARD BRUCE DPresident & CEOAug 11Sale251.8812,0003,022,60480,086Aug 14 04:21 PM
Christopher M TodoroffSr. VP and General CounselAug 10Option Exercise165.6920,9433,470,07230,935Aug 14 04:16 PM
Christopher M TodoroffSr. VP and General CounselAug 10Sale252.5222,9355,791,4918,000Aug 14 04:16 PM
LeClaire Brian P.SVP & Chief Information Off.Jun 28Option Exercise164.654,971818,45014,258Jun 29 02:15 PM
LeClaire Brian P.SVP & Chief Information Off.Jun 28Sale240.004,9711,193,0169,287Jun 29 02:15 PM
Kane Brian ASVP & Chief Financial OfficerJun 02Option Exercise0.0024,821025,819Jun 06 04:19 PM
MARGULIS HEIDI SSenior V.P. -Corporate AffairsMay 26Sale231.961,500347,9338,150May 30 04:22 PM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerMay 12Option Exercise92.2529,3762,709,96138,037May 15 04:45 PM
BILNEY JODY LSVP & Chief Consumer OfficerMay 05Sale230.164,6001,058,7438,978May 09 01:47 PM
BROUSSARD BRUCE DPresident & CEOMay 04Option Exercise165.69118,23119,589,848210,317May 04 04:04 PM
Huval Timothy S.Senior VP & Chief HR OfficerMay 04Option Exercise166.2213,9392,316,89830,573May 04 04:05 PM
BROUSSARD BRUCE DPresident & CEOMay 04Sale225.82118,23126,699,14992,086May 04 04:04 PM
Huval Timothy S.Senior VP & Chief HR OfficerMay 04Sale225.8613,9393,148,30616,634May 04 04:05 PM
BILNEY JODY LSVP & Chief Consumer OfficerMar 21Sale213.804,348929,62013,578Mar 22 01:01 PM
KAY CHRISTOPHER ESVP & Chief Innovation OfficerMar 17Option Exercise0.006,13406,837Mar 21 12:09 PM
MURRAY JAMES EEVP & COOMar 06Option Exercise164.6510,8461,785,74045,635Mar 07 04:06 PM
MURRAY JAMES EEVP & COOMar 06Sale213.6520,3054,338,2300Mar 07 04:06 PM
MURRAY JAMES EEVP & COOMar 06Sale213.5510,8462,316,14834,789Mar 07 04:06 PM
Dunbar Webster RoyDirectorMar 03Sale213.123,000639,3601,166Mar 06 04:55 PM
Zipperle Cynthia HVice President, CAO,ControllerMar 03Sale213.371,885402,2063,736Mar 06 04:48 PM
PETERSON MARISSA TDirectorFeb 27Sale207.523,305685,863761Mar 01 04:18 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 24Option Exercise164.654,971818,45014,258Feb 27 02:53 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 24Sale204.814,9711,018,1029,287Feb 27 02:53 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 22Option Exercise119.7314,6251,751,00537,157Feb 22 07:59 PM
BEVERIDGE, ROY ASr. VP & Chief Medical OfficerFeb 22Sale205.734,832994,0908,931Feb 22 06:47 PM
HUNTER CHRISTOPHER H.SVP and Chief Strategy OfficerFeb 22Sale205.204,020824,9208,966Feb 22 06:53 PM
MURRAY JAMES EEVP & COOFeb 22Sale204.699,5231,949,21659,932Feb 22 09:06 PM
LeClaire Brian P.SVP & Chief Information Off.Feb 22Sale205.2426,8945,519,6179,289Feb 22 07:59 PM
Christopher M TodoroffSr. VP and General CounselFeb 21Option Exercise95.0119,9471,895,18638,978